date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.19606842
## 0610009E02Rik 2.50381380
## 0610009L18Rik 0.71226654
## 0610010K14Rik -0.06247159
## 0610012G03Rik -0.08438765
## 0610030E20Rik -0.30737084
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 1604 |
num_genes_in_profile | 17009 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8305 |
num_profile_genes_not_in_sets | 8704 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Gene sets metrics | |
---|---|
num_genesets | 1604 |
num_genesets_excluded | 440 |
num_genesets_included | 1164 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.96e-03 | 0.566 | 0.05280 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 7.94e-05 | 0.553 | 0.00924 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.89e-05 | 0.519 | 0.00503 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.23e-03 | -0.513 | 0.07670 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 7.09e-04 | 0.505 | 0.03440 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.92e-03 | -0.503 | 0.12300 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.73e-03 | 0.495 | 0.12400 |
CGMP EFFECTS | 15 | 9.40e-04 | 0.493 | 0.03650 |
DNA METHYLATION | 20 | 4.42e-04 | -0.454 | 0.02450 |
LGI ADAM INTERACTIONS | 14 | 3.48e-03 | 0.451 | 0.08100 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 6.92e-03 | 0.450 | 0.12400 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.02e-03 | 0.447 | 0.03790 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.12e-02 | -0.442 | 0.14300 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.26e-03 | 0.439 | 0.04080 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 12 | 8.52e-03 | -0.439 | 0.13000 |
MUCOPOLYSACCHARIDOSES | 11 | 1.20e-02 | 0.437 | 0.14800 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 2.84e-05 | 0.434 | 0.00456 |
SHC MEDIATED CASCADE FGFR4 | 11 | 1.52e-02 | -0.423 | 0.17500 |
SIGNALING BY HIPPO | 20 | 1.24e-03 | -0.417 | 0.04080 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 1.01e-02 | -0.412 | 0.13700 |
HSF1 ACTIVATION | 27 | 2.40e-04 | -0.408 | 0.01740 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.31e-03 | 0.405 | 0.04130 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.69e-02 | -0.404 | 0.23200 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.13e-02 | 0.401 | 0.20800 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.18e-02 | -0.399 | 0.21000 |
CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 2.97e-04 | -0.395 | 0.01820 |
CROSSLINKING OF COLLAGEN FIBRILS | 14 | 1.12e-02 | 0.391 | 0.14300 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.24e-02 | 0.391 | 0.24800 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 1.52e-02 | -0.389 | 0.17500 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.99e-02 | -0.388 | 0.20200 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 1.21e-02 | 0.387 | 0.14800 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.02e-02 | -0.383 | 0.13700 |
ATTENUATION PHASE | 25 | 9.34e-04 | -0.382 | 0.03650 |
PI 3K CASCADE FGFR4 | 11 | 3.04e-02 | -0.377 | 0.24200 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.82e-03 | 0.376 | 0.05050 |
DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 2.77e-02 | -0.367 | 0.23500 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 1.82e-03 | -0.360 | 0.05050 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.02e-02 | 0.360 | 0.13700 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 3.88e-02 | -0.360 | 0.27500 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.94e-02 | 0.359 | 0.30600 |
INTERLEUKIN 10 SIGNALING | 19 | 7.48e-03 | -0.354 | 0.12600 |
INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 1.04e-03 | 0.352 | 0.03790 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.27e-02 | -0.352 | 0.21400 |
FORMATION OF THE CORNIFIED ENVELOPE | 26 | 2.04e-03 | 0.349 | 0.05280 |
KERATINIZATION | 26 | 2.04e-03 | 0.349 | 0.05280 |
FRS MEDIATED FGFR4 SIGNALING | 13 | 2.97e-02 | -0.348 | 0.24200 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.96e-02 | 0.348 | 0.20200 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 3.12e-02 | -0.345 | 0.24200 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 4.41e-03 | -0.343 | 0.09680 |
DSCAM INTERACTIONS | 10 | 6.07e-02 | 0.343 | 0.33400 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.96e-03 | 0.566000 | 5.28e-02 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 7.94e-05 | 0.553000 | 9.24e-03 |
SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.89e-05 | 0.519000 | 5.03e-03 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.23e-03 | -0.513000 | 7.67e-02 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 7.09e-04 | 0.505000 | 3.44e-02 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 5.92e-03 | -0.503000 | 1.23e-01 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 6.73e-03 | 0.495000 | 1.24e-01 |
CGMP EFFECTS | 15 | 9.40e-04 | 0.493000 | 3.65e-02 |
DNA METHYLATION | 20 | 4.42e-04 | -0.454000 | 2.45e-02 |
LGI ADAM INTERACTIONS | 14 | 3.48e-03 | 0.451000 | 8.10e-02 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 6.92e-03 | 0.450000 | 1.24e-01 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 1.02e-03 | 0.447000 | 3.79e-02 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 1.12e-02 | -0.442000 | 1.43e-01 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 1.26e-03 | 0.439000 | 4.08e-02 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 12 | 8.52e-03 | -0.439000 | 1.30e-01 |
MUCOPOLYSACCHARIDOSES | 11 | 1.20e-02 | 0.437000 | 1.48e-01 |
TRAFFICKING OF AMPA RECEPTORS | 31 | 2.84e-05 | 0.434000 | 4.56e-03 |
SHC MEDIATED CASCADE FGFR4 | 11 | 1.52e-02 | -0.423000 | 1.75e-01 |
SIGNALING BY HIPPO | 20 | 1.24e-03 | -0.417000 | 4.08e-02 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 1.01e-02 | -0.412000 | 1.37e-01 |
HSF1 ACTIVATION | 27 | 2.40e-04 | -0.408000 | 1.74e-02 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.31e-03 | 0.405000 | 4.13e-02 |
SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.69e-02 | -0.404000 | 2.32e-01 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 2.13e-02 | 0.401000 | 2.08e-01 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.18e-02 | -0.399000 | 2.10e-01 |
CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 2.97e-04 | -0.395000 | 1.82e-02 |
CROSSLINKING OF COLLAGEN FIBRILS | 14 | 1.12e-02 | 0.391000 | 1.43e-01 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.24e-02 | 0.391000 | 2.48e-01 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 1.52e-02 | -0.389000 | 1.75e-01 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.99e-02 | -0.388000 | 2.02e-01 |
RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 1.21e-02 | 0.387000 | 1.48e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 1.02e-02 | -0.383000 | 1.37e-01 |
ATTENUATION PHASE | 25 | 9.34e-04 | -0.382000 | 3.65e-02 |
PI 3K CASCADE FGFR4 | 11 | 3.04e-02 | -0.377000 | 2.42e-01 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.82e-03 | 0.376000 | 5.05e-02 |
DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 2.77e-02 | -0.367000 | 2.35e-01 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 1.82e-03 | -0.360000 | 5.05e-02 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.02e-02 | 0.360000 | 1.37e-01 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 3.88e-02 | -0.360000 | 2.75e-01 |
RRNA PROCESSING IN THE MITOCHONDRION | 10 | 4.94e-02 | 0.359000 | 3.06e-01 |
INTERLEUKIN 10 SIGNALING | 19 | 7.48e-03 | -0.354000 | 1.26e-01 |
INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 1.04e-03 | 0.352000 | 3.79e-02 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.27e-02 | -0.352000 | 2.14e-01 |
FORMATION OF THE CORNIFIED ENVELOPE | 26 | 2.04e-03 | 0.349000 | 5.28e-02 |
KERATINIZATION | 26 | 2.04e-03 | 0.349000 | 5.28e-02 |
FRS MEDIATED FGFR4 SIGNALING | 13 | 2.97e-02 | -0.348000 | 2.42e-01 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.96e-02 | 0.348000 | 2.02e-01 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 3.12e-02 | -0.345000 | 2.42e-01 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 4.41e-03 | -0.343000 | 9.68e-02 |
DSCAM INTERACTIONS | 10 | 6.07e-02 | 0.343000 | 3.34e-01 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 6.61e-03 | 0.342000 | 1.24e-01 |
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 6.62e-03 | 0.342000 | 1.24e-01 |
RA BIOSYNTHESIS PATHWAY | 14 | 2.83e-02 | -0.339000 | 2.37e-01 |
ENDOSOMAL VACUOLAR PATHWAY | 11 | 5.20e-02 | -0.338000 | 3.09e-01 |
BIOTIN TRANSPORT AND METABOLISM | 11 | 5.24e-02 | 0.338000 | 3.09e-01 |
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 1.33e-02 | -0.337000 | 1.59e-01 |
VOLTAGE GATED POTASSIUM CHANNELS | 40 | 2.39e-04 | 0.336000 | 1.74e-02 |
COMPLEMENT CASCADE | 26 | 3.16e-03 | -0.334000 | 7.67e-02 |
CELLULAR HEXOSE TRANSPORT | 10 | 7.07e-02 | 0.330000 | 3.55e-01 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 7.17e-02 | 0.329000 | 3.55e-01 |
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 36 | 6.83e-04 | 0.327000 | 3.44e-02 |
SYNTHESIS OF PE | 13 | 4.15e-02 | -0.327000 | 2.89e-01 |
SPRY REGULATION OF FGF SIGNALING | 16 | 2.39e-02 | 0.326000 | 2.19e-01 |
SHC MEDIATED CASCADE FGFR3 | 13 | 4.24e-02 | -0.325000 | 2.89e-01 |
LONG TERM POTENTIATION | 23 | 7.13e-03 | 0.324000 | 1.24e-01 |
ENOS ACTIVATION | 11 | 6.57e-02 | -0.321000 | 3.40e-01 |
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 12 | 5.52e-02 | -0.320000 | 3.15e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 18 | 2.06e-02 | -0.315000 | 2.05e-01 |
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 22 | 1.08e-02 | -0.314000 | 1.42e-01 |
KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 3.05e-02 | 0.312000 | 2.42e-01 |
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 13 | 5.15e-02 | -0.312000 | 3.09e-01 |
THE NLRP3 INFLAMMASOME | 15 | 3.72e-02 | -0.311000 | 2.73e-01 |
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.01e-02 | 0.310000 | 1.37e-01 |
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 1.57e-02 | -0.304000 | 1.79e-01 |
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 2.60e-02 | -0.303000 | 2.27e-01 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 1.72e-02 | -0.300000 | 1.91e-01 |
ANCHORING FIBRIL FORMATION | 13 | 6.16e-02 | 0.299000 | 3.37e-01 |
INTERFERON GAMMA SIGNALING | 78 | 5.21e-06 | -0.298000 | 3.03e-03 |
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.56e-02 | -0.298000 | 2.98e-01 |
REGULATED PROTEOLYSIS OF P75NTR | 12 | 7.38e-02 | -0.298000 | 3.55e-01 |
MET ACTIVATES RAS SIGNALING | 10 | 1.09e-01 | -0.293000 | 4.37e-01 |
CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 3.20e-02 | -0.292000 | 2.47e-01 |
IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 9.59e-02 | -0.290000 | 4.13e-01 |
OLFACTORY SIGNALING PATHWAY | 31 | 5.30e-03 | -0.289000 | 1.12e-01 |
TRAF6 MEDIATED NF KB ACTIVATION | 22 | 1.92e-02 | -0.288000 | 2.02e-01 |
MET ACTIVATES RAP1 AND RAC1 | 11 | 9.82e-02 | -0.288000 | 4.19e-01 |
PI 3K CASCADE FGFR3 | 13 | 7.40e-02 | -0.286000 | 3.55e-01 |
ERKS ARE INACTIVATED | 13 | 7.45e-02 | 0.286000 | 3.55e-01 |
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.51e-02 | -0.285000 | 3.38e-01 |
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 79 | 1.24e-05 | -0.285000 | 3.18e-03 |
DISEASES OF IMMUNE SYSTEM | 23 | 1.85e-02 | -0.284000 | 1.99e-01 |
INTERFERON ALPHA BETA SIGNALING | 56 | 2.75e-04 | -0.281000 | 1.78e-02 |
NEUREXINS AND NEUROLIGINS | 54 | 3.88e-04 | 0.279000 | 2.26e-02 |
FORMATION OF APOPTOSOME | 10 | 1.27e-01 | -0.278000 | 4.69e-01 |
CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 6.36e-02 | -0.277000 | 3.38e-01 |
FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 6.01e-03 | 0.276000 | 1.23e-01 |
DISEASES OF DNA REPAIR | 11 | 1.16e-01 | 0.274000 | 4.54e-01 |
GLYCOGEN METABOLISM | 25 | 1.79e-02 | -0.274000 | 1.97e-01 |
FRS MEDIATED FGFR3 SIGNALING | 15 | 6.66e-02 | -0.274000 | 3.42e-01 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 8.79e-02 | 0.273000 | 3.97e-01 |
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 5.12e-02 | 0.273000 | 3.09e-01 |
REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 1.18e-01 | 0.272000 | 4.55e-01 |
RHO GTPASES ACTIVATE NADPH OXIDASES | 19 | 4.22e-02 | 0.269000 | 2.89e-01 |
INITIAL TRIGGERING OF COMPLEMENT | 11 | 1.23e-01 | -0.269000 | 4.67e-01 |
SIGNALING BY ERBB2 ECD MUTANTS | 16 | 6.29e-02 | -0.269000 | 3.38e-01 |
SIGNALING BY FGFR4 IN DISEASE | 10 | 1.42e-01 | -0.268000 | 4.88e-01 |
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 2.65e-02 | 0.267000 | 2.30e-01 |
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 9.56e-02 | -0.267000 | 4.13e-01 |
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 7.40e-02 | -0.267000 | 3.55e-01 |
APOPTOSIS INDUCED DNA FRAGMENTATION | 10 | 1.46e-01 | -0.266000 | 4.91e-01 |
CA DEPENDENT EVENTS | 36 | 6.22e-03 | 0.264000 | 1.24e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 4.21e-02 | -0.263000 | 2.89e-01 |
ERK MAPK TARGETS | 22 | 3.31e-02 | 0.263000 | 2.51e-01 |
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 3.14e-05 | 0.261000 | 4.56e-03 |
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.08e-02 | 0.260000 | 2.42e-01 |
SIGNALING BY BMP | 25 | 2.47e-02 | -0.259000 | 2.25e-01 |
TIGHT JUNCTION INTERACTIONS | 16 | 7.36e-02 | -0.258000 | 3.55e-01 |
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 4.68e-02 | 0.257000 | 2.99e-01 |
RHO GTPASES ACTIVATE KTN1 | 11 | 1.41e-01 | -0.256000 | 4.88e-01 |
SCAVENGING BY CLASS A RECEPTORS | 13 | 1.10e-01 | -0.256000 | 4.37e-01 |
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 12 | 1.25e-01 | 0.256000 | 4.69e-01 |
SIGNALING BY ERBB2 IN CANCER | 25 | 2.97e-02 | -0.251000 | 2.42e-01 |
CRMPS IN SEMA3A SIGNALING | 16 | 8.36e-02 | 0.250000 | 3.86e-01 |
PHASE 0 RAPID DEPOLARISATION | 31 | 1.63e-02 | 0.249000 | 1.84e-01 |
UNWINDING OF DNA | 12 | 1.35e-01 | 0.249000 | 4.79e-01 |
EFFECTS OF PIP2 HYDROLYSIS | 27 | 2.50e-02 | 0.249000 | 2.26e-01 |
RESOLUTION OF ABASIC SITES AP SITES | 38 | 7.88e-03 | 0.249000 | 1.26e-01 |
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 1.74e-01 | 0.248000 | 5.31e-01 |
INFLAMMASOMES | 19 | 6.28e-02 | -0.247000 | 3.38e-01 |
HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 51 | 2.33e-03 | 0.246000 | 5.90e-02 |
NCAM SIGNALING FOR NEURITE OUT GROWTH | 57 | 1.35e-03 | 0.245000 | 4.14e-02 |
PRC2 METHYLATES HISTONES AND DNA | 29 | 2.23e-02 | -0.245000 | 2.13e-01 |
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 45 | 4.70e-03 | -0.244000 | 1.01e-01 |
MEIOTIC RECOMBINATION | 38 | 9.40e-03 | -0.244000 | 1.37e-01 |
DAG AND IP3 SIGNALING | 40 | 7.99e-03 | 0.242000 | 1.26e-01 |
PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 1.46e-01 | -0.242000 | 4.91e-01 |
HIV TRANSCRIPTION ELONGATION | 42 | 7.02e-03 | 0.240000 | 1.24e-01 |
OVARIAN TUMOR DOMAIN PROTEASES | 36 | 1.26e-02 | -0.240000 | 1.53e-01 |
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 1.89e-01 | 0.240000 | 5.51e-01 |
COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 8.82e-05 | 0.239000 | 9.33e-03 |
VLDLR INTERNALISATION AND DEGRADATION | 12 | 1.53e-01 | 0.238000 | 5.02e-01 |
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 39 | 1.01e-02 | -0.238000 | 1.37e-01 |
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 25 | 4.03e-02 | -0.237000 | 2.84e-01 |
RHOBTB2 GTPASE CYCLE | 23 | 5.06e-02 | -0.236000 | 3.09e-01 |
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.58e-01 | -0.235000 | 5.07e-01 |
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 1.42e-01 | -0.235000 | 4.88e-01 |
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 64 | 1.23e-03 | -0.234000 | 4.08e-02 |
ACYL CHAIN REMODELLING OF PS | 14 | 1.31e-01 | 0.233000 | 4.72e-01 |
AMINE LIGAND BINDING RECEPTORS | 31 | 2.58e-02 | 0.231000 | 2.27e-01 |
IRAK4 DEFICIENCY TLR2 4 | 12 | 1.67e-01 | -0.230000 | 5.22e-01 |
ERYTHROPOIETIN ACTIVATES RAS | 13 | 1.51e-01 | -0.230000 | 5.00e-01 |
FCERI MEDIATED CA 2 MOBILIZATION | 25 | 4.77e-02 | -0.229000 | 2.99e-01 |
CALNEXIN CALRETICULIN CYCLE | 26 | 4.38e-02 | -0.228000 | 2.94e-01 |
POTASSIUM CHANNELS | 90 | 1.86e-04 | 0.228000 | 1.67e-02 |
SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 1.04e-01 | -0.228000 | 4.27e-01 |
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 1.74e-01 | 0.226000 | 5.31e-01 |
SURFACTANT METABOLISM | 16 | 1.17e-01 | -0.226000 | 4.54e-01 |
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 1.77e-01 | -0.225000 | 5.33e-01 |
NONHOMOLOGOUS END JOINING NHEJ | 44 | 9.97e-03 | -0.225000 | 1.37e-01 |
GLUCONEOGENESIS | 27 | 4.40e-02 | 0.224000 | 2.94e-01 |
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 1.63e-01 | 0.224000 | 5.15e-01 |
PROCESSING OF INTRONLESS PRE MRNAS | 19 | 9.23e-02 | 0.223000 | 4.07e-01 |
GLYCOGEN SYNTHESIS | 14 | 1.49e-01 | -0.223000 | 4.96e-01 |
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 1.35e-01 | -0.223000 | 4.79e-01 |
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 45 | 9.80e-03 | -0.223000 | 1.37e-01 |
HS GAG BIOSYNTHESIS | 29 | 3.83e-02 | 0.222000 | 2.74e-01 |
NCAM1 INTERACTIONS | 37 | 1.99e-02 | 0.221000 | 2.02e-01 |
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 6.70e-02 | -0.221000 | 3.42e-01 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 2.59e-04 | -0.217000 | 1.78e-02 |
RECYCLING PATHWAY OF L1 | 40 | 1.87e-02 | 0.215000 | 1.99e-01 |
DARPP 32 EVENTS | 23 | 7.44e-02 | 0.215000 | 3.55e-01 |
GP1B IX V ACTIVATION SIGNALLING | 11 | 2.17e-01 | 0.215000 | 5.93e-01 |
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 2.42e-01 | 0.214000 | 6.30e-01 |
NETRIN 1 SIGNALING | 48 | 1.06e-02 | 0.213000 | 1.40e-01 |
AMINO ACIDS REGULATE MTORC1 | 51 | 8.59e-03 | 0.213000 | 1.30e-01 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 3.46e-02 | -0.213000 | 2.57e-01 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 1.42e-01 | -0.212000 | 4.88e-01 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.19e-01 | 0.212000 | 4.58e-01 |
RHOBTB3 ATPASE CYCLE | 10 | 2.46e-01 | -0.212000 | 6.35e-01 |
INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 7.30e-02 | -0.211000 | 3.55e-01 |
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 84 | 8.13e-04 | 0.211000 | 3.51e-02 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 107 | 1.62e-04 | -0.211000 | 1.57e-02 |
EUKARYOTIC TRANSLATION ELONGATION | 88 | 6.66e-04 | -0.210000 | 3.44e-02 |
NEPHRIN FAMILY INTERACTIONS | 22 | 9.07e-02 | 0.208000 | 4.01e-01 |
HDR THROUGH MMEJ ALT NHEJ | 10 | 2.55e-01 | 0.208000 | 6.39e-01 |
AMYLOID FIBER FORMATION | 57 | 6.79e-03 | -0.207000 | 1.24e-01 |
RHOBTB GTPASE CYCLE | 35 | 3.43e-02 | -0.207000 | 2.56e-01 |
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 9.32e-02 | 0.207000 | 4.10e-01 |
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 14 | 1.82e-01 | -0.206000 | 5.40e-01 |
HS GAG DEGRADATION | 20 | 1.10e-01 | 0.206000 | 4.37e-01 |
MTORC1 MEDIATED SIGNALLING | 24 | 8.13e-02 | 0.206000 | 3.80e-01 |
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 22 | 9.53e-02 | 0.205000 | 4.13e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 8.88e-02 | -0.205000 | 3.97e-01 |
CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 1.73e-01 | 0.203000 | 5.31e-01 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 2.05e-01 | 0.203000 | 5.78e-01 |
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 1.90e-01 | -0.202000 | 5.51e-01 |
RHOBTB1 GTPASE CYCLE | 23 | 9.40e-02 | -0.202000 | 4.10e-01 |
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 1.28e-01 | -0.202000 | 4.69e-01 |
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 2.57e-02 | -0.201000 | 2.27e-01 |
SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 2.59e-02 | -0.201000 | 2.27e-01 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.28e-01 | -0.201000 | 6.15e-01 |
PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 6.65e-02 | 0.200000 | 3.42e-01 |
RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 3.80e-02 | 0.200000 | 2.74e-01 |
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 23 | 9.73e-02 | -0.200000 | 4.17e-01 |
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 2.53e-01 | 0.199000 | 6.37e-01 |
PI 3K CASCADE FGFR2 | 16 | 1.68e-01 | -0.199000 | 5.24e-01 |
HSF1 DEPENDENT TRANSACTIVATION | 35 | 4.17e-02 | -0.199000 | 2.89e-01 |
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 1.25e-01 | 0.198000 | 4.69e-01 |
FRS MEDIATED FGFR2 SIGNALING | 18 | 1.45e-01 | -0.198000 | 4.91e-01 |
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 2.40e-01 | 0.196000 | 6.29e-01 |
RECEPTOR MEDIATED MITOPHAGY | 11 | 2.60e-01 | 0.196000 | 6.43e-01 |
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 6.41e-02 | 0.195000 | 3.38e-01 |
SIGNALING BY PDGFR IN DISEASE | 20 | 1.31e-01 | -0.195000 | 4.72e-01 |
PLATELET SENSITIZATION BY LDL | 15 | 1.91e-01 | -0.195000 | 5.51e-01 |
CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 1.42e-01 | 0.194000 | 4.88e-01 |
HIV ELONGATION ARREST AND RECOVERY | 32 | 5.82e-02 | 0.194000 | 3.28e-01 |
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 2.13e-01 | -0.192000 | 5.89e-01 |
REGULATION OF FZD BY UBIQUITINATION | 20 | 1.39e-01 | -0.191000 | 4.88e-01 |
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 1.14e-02 | 0.190000 | 1.44e-01 |
PURINE SALVAGE | 12 | 2.54e-01 | 0.190000 | 6.39e-01 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 1.75e-01 | 0.190000 | 5.31e-01 |
INSULIN RECEPTOR RECYCLING | 20 | 1.42e-01 | 0.190000 | 4.88e-01 |
CD209 DC SIGN SIGNALING | 18 | 1.65e-01 | -0.189000 | 5.16e-01 |
SIGNALING BY CSF3 G CSF | 29 | 7.85e-02 | -0.189000 | 3.69e-01 |
SIGNALING BY ERBB4 | 57 | 1.38e-02 | -0.189000 | 1.63e-01 |
DUAL INCISION IN GG NER | 41 | 3.70e-02 | 0.188000 | 2.73e-01 |
INTERLEUKIN 37 SIGNALING | 19 | 1.57e-01 | -0.188000 | 5.07e-01 |
HEME BIOSYNTHESIS | 13 | 2.44e-01 | 0.187000 | 6.33e-01 |
COHESIN LOADING ONTO CHROMATIN | 10 | 3.09e-01 | -0.186000 | 6.89e-01 |
SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.88e-01 | -0.185000 | 6.70e-01 |
RUNX3 REGULATES NOTCH SIGNALING | 13 | 2.51e-01 | -0.184000 | 6.35e-01 |
SEROTONIN RECEPTORS | 10 | 3.15e-01 | 0.183000 | 6.92e-01 |
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 2.95e-01 | -0.182000 | 6.77e-01 |
P38MAPK EVENTS | 12 | 2.76e-01 | -0.182000 | 6.59e-01 |
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 23 | 1.31e-01 | -0.182000 | 4.72e-01 |
GLYCOSAMINOGLYCAN METABOLISM | 114 | 8.11e-04 | 0.182000 | 3.51e-02 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 3.20e-01 | 0.181000 | 6.93e-01 |
PENTOSE PHOSPHATE PATHWAY | 13 | 2.58e-01 | -0.181000 | 6.43e-01 |
DNA DAMAGE RECOGNITION IN GG NER | 38 | 5.44e-02 | 0.180000 | 3.12e-01 |
BUDDING AND MATURATION OF HIV VIRION | 27 | 1.05e-01 | 0.180000 | 4.27e-01 |
SODIUM CALCIUM EXCHANGERS | 10 | 3.24e-01 | 0.180000 | 6.93e-01 |
NEURONAL SYSTEM | 364 | 3.95e-09 | 0.180000 | 4.60e-06 |
VXPX CARGO TARGETING TO CILIUM | 19 | 1.78e-01 | 0.179000 | 5.35e-01 |
RNA POLYMERASE III CHAIN ELONGATION | 18 | 1.91e-01 | 0.178000 | 5.51e-01 |
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 2.34e-01 | 0.178000 | 6.24e-01 |
ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 3.31e-01 | 0.178000 | 6.94e-01 |
EARLY PHASE OF HIV LIFE CYCLE | 14 | 2.50e-01 | -0.177000 | 6.35e-01 |
ACYL CHAIN REMODELLING OF PG | 10 | 3.33e-01 | 0.177000 | 6.95e-01 |
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 7.43e-02 | -0.177000 | 3.55e-01 |
L1CAM INTERACTIONS | 109 | 1.44e-03 | 0.177000 | 4.31e-02 |
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 1.07e-01 | 0.176000 | 4.31e-01 |
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 1.07e-01 | 0.176000 | 4.31e-01 |
DEADENYLATION OF MRNA | 25 | 1.28e-01 | 0.176000 | 4.69e-01 |
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.27e-02 | 0.175000 | 3.09e-01 |
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 33 | 8.22e-02 | -0.175000 | 3.83e-01 |
GLUCOSE METABOLISM | 79 | 7.36e-03 | 0.174000 | 1.26e-01 |
RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 9.38e-02 | 0.174000 | 4.10e-01 |
SIGNALING BY FGFR1 IN DISEASE | 32 | 8.95e-02 | -0.173000 | 3.98e-01 |
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 2.62e-01 | 0.173000 | 6.44e-01 |
ANTIGEN PROCESSING CROSS PRESENTATION | 95 | 3.66e-03 | -0.173000 | 8.35e-02 |
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 51 | 3.32e-02 | -0.172000 | 2.51e-01 |
DERMATAN SULFATE BIOSYNTHESIS | 11 | 3.22e-01 | 0.172000 | 6.93e-01 |
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 2.35e-01 | 0.172000 | 6.25e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 1.04e-01 | 0.171000 | 4.27e-01 |
NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 1.30e-01 | 0.171000 | 4.72e-01 |
VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 1.31e-01 | -0.171000 | 4.72e-01 |
BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 2.86e-01 | -0.171000 | 6.70e-01 |
RIPK1 MEDIATED REGULATED NECROSIS | 25 | 1.40e-01 | -0.171000 | 4.88e-01 |
INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 2.88e-01 | -0.170000 | 6.70e-01 |
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 1.87e-01 | -0.170000 | 5.48e-01 |
NUCLEOTIDE SALVAGE | 21 | 1.80e-01 | 0.169000 | 5.38e-01 |
PRE NOTCH EXPRESSION AND PROCESSING | 64 | 2.03e-02 | -0.168000 | 2.04e-01 |
RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 4.72e-02 | 0.167000 | 2.99e-01 |
PURINE CATABOLISM | 16 | 2.48e-01 | 0.167000 | 6.35e-01 |
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.18e-01 | -0.167000 | 6.92e-01 |
RHO GTPASES ACTIVATE PKNS | 48 | 4.60e-02 | -0.167000 | 2.98e-01 |
REGULATION OF IFNG SIGNALING | 13 | 2.99e-01 | -0.166000 | 6.78e-01 |
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 1.51e-01 | -0.166000 | 5.00e-01 |
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 1.10e-01 | 0.166000 | 4.37e-01 |
ANTIMICROBIAL PEPTIDES | 16 | 2.51e-01 | -0.166000 | 6.35e-01 |
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 3.21e-01 | 0.165000 | 6.93e-01 |
FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 3.09e-02 | 0.165000 | 2.42e-01 |
TBC RABGAPS | 42 | 6.43e-02 | 0.165000 | 3.38e-01 |
APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 2.27e-01 | -0.165000 | 6.12e-01 |
ACYL CHAIN REMODELLING OF PC | 17 | 2.40e-01 | 0.165000 | 6.29e-01 |
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 1.57e-01 | 0.163000 | 5.07e-01 |
PI3K EVENTS IN ERBB2 SIGNALING | 15 | 2.73e-01 | -0.163000 | 6.55e-01 |
ER TO GOLGI ANTEROGRADE TRANSPORT | 140 | 8.54e-04 | 0.163000 | 3.55e-02 |
BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 1.76e-01 | -0.163000 | 5.31e-01 |
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 1.23e-01 | 0.163000 | 4.67e-01 |
SELENOAMINO ACID METABOLISM | 110 | 3.21e-03 | -0.163000 | 7.67e-02 |
ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.98e-01 | -0.162000 | 5.62e-01 |
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 2.21e-01 | 0.162000 | 5.99e-01 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 2.47e-01 | -0.162000 | 6.35e-01 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 3.76e-01 | 0.162000 | 7.29e-01 |
SARS COV 1 INFECTION | 48 | 5.28e-02 | 0.162000 | 3.09e-01 |
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 32 | 1.17e-01 | -0.160000 | 4.54e-01 |
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 3.18e-01 | -0.160000 | 6.92e-01 |
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 1.60e-01 | -0.159000 | 5.11e-01 |
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 3.61e-01 | -0.159000 | 7.24e-01 |
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 2.44e-01 | 0.159000 | 6.33e-01 |
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 1.40e-01 | -0.159000 | 4.88e-01 |
GLYCOLYSIS | 65 | 2.76e-02 | 0.158000 | 2.35e-01 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 3.07e-01 | 0.158000 | 6.89e-01 |
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 4.95e-02 | -0.158000 | 3.06e-01 |
SIGNALING BY EGFR IN CANCER | 22 | 2.02e-01 | -0.157000 | 5.71e-01 |
JOSEPHIN DOMAIN DUBS | 11 | 3.68e-01 | 0.157000 | 7.28e-01 |
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 47 | 6.39e-02 | -0.156000 | 3.38e-01 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.52e-01 | -0.155000 | 7.13e-01 |
FGFR2 LIGAND BINDING AND ACTIVATION | 11 | 3.75e-01 | -0.154000 | 7.29e-01 |
FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 5.26e-02 | 0.154000 | 3.09e-01 |
METABOLISM OF PORPHYRINS | 19 | 2.47e-01 | 0.154000 | 6.35e-01 |
HDACS DEACETYLATE HISTONES | 47 | 6.91e-02 | -0.153000 | 3.50e-01 |
INTRAFLAGELLAR TRANSPORT | 49 | 6.45e-02 | 0.153000 | 3.38e-01 |
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 4.04e-01 | -0.152000 | 7.51e-01 |
SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 3.42e-01 | -0.152000 | 7.02e-01 |
PROTEIN UBIQUITINATION | 70 | 2.79e-02 | -0.152000 | 2.35e-01 |
MRNA SPLICING MINOR PATHWAY | 52 | 5.81e-02 | 0.152000 | 3.28e-01 |
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 3.09e-01 | -0.152000 | 6.89e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 2.65e-01 | -0.152000 | 6.48e-01 |
FORMATION OF INCISION COMPLEX IN GG NER | 43 | 8.55e-02 | 0.152000 | 3.92e-01 |
ESTROGEN DEPENDENT GENE EXPRESSION | 102 | 8.28e-03 | -0.151000 | 1.28e-01 |
ERBB2 REGULATES CELL MOTILITY | 14 | 3.27e-01 | -0.151000 | 6.94e-01 |
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 2.31e-01 | 0.151000 | 6.19e-01 |
N GLYCAN ANTENNAE ELONGATION | 15 | 3.11e-01 | -0.151000 | 6.90e-01 |
TRNA PROCESSING | 105 | 7.72e-03 | 0.151000 | 1.26e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 1.70e-01 | 0.150000 | 5.26e-01 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 3.92e-01 | -0.149000 | 7.45e-01 |
DUAL INCISION IN TC NER | 65 | 3.76e-02 | 0.149000 | 2.74e-01 |
NUCLEAR ENVELOPE BREAKDOWN | 49 | 7.15e-02 | 0.149000 | 3.55e-01 |
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 2.31e-02 | 0.149000 | 2.15e-01 |
ION HOMEOSTASIS | 48 | 7.45e-02 | 0.149000 | 3.55e-01 |
TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 4.63e-02 | 0.149000 | 2.98e-01 |
DAP12 INTERACTIONS | 31 | 1.53e-01 | -0.148000 | 5.02e-01 |
VIRAL MESSENGER RNA SYNTHESIS | 42 | 9.64e-02 | 0.148000 | 4.14e-01 |
EGFR DOWNREGULATION | 28 | 1.75e-01 | 0.148000 | 5.31e-01 |
PKMTS METHYLATE HISTONE LYSINES | 49 | 7.35e-02 | -0.148000 | 3.55e-01 |
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 3.57e-01 | -0.148000 | 7.21e-01 |
DISEASES OF PROGRAMMED CELL DEATH | 54 | 6.08e-02 | -0.148000 | 3.34e-01 |
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 4.47e-02 | 0.147000 | 2.96e-01 |
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.08e-01 | -0.147000 | 6.89e-01 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 3.58e-01 | -0.147000 | 7.21e-01 |
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 1.94e-01 | 0.147000 | 5.56e-01 |
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 2.94e-01 | 0.147000 | 6.77e-01 |
INTERFERON SIGNALING | 166 | 1.11e-03 | -0.147000 | 3.92e-02 |
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 177 | 8.02e-04 | 0.146000 | 3.51e-02 |
INTERLEUKIN 7 SIGNALING | 20 | 2.58e-01 | 0.146000 | 6.43e-01 |
NUCLEAR ENVELOPE NE REASSEMBLY | 64 | 4.46e-02 | 0.145000 | 2.96e-01 |
RAP1 SIGNALLING | 15 | 3.32e-01 | 0.145000 | 6.95e-01 |
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 3.86e-01 | -0.145000 | 7.42e-01 |
MTOR SIGNALLING | 40 | 1.14e-01 | 0.144000 | 4.50e-01 |
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 83 | 2.37e-02 | -0.144000 | 2.19e-01 |
KERATAN SULFATE DEGRADATION | 11 | 4.09e-01 | 0.144000 | 7.51e-01 |
INTRA GOLGI TRAFFIC | 43 | 1.04e-01 | 0.143000 | 4.27e-01 |
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 49 | 8.27e-02 | -0.143000 | 3.84e-01 |
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 1.05e-01 | 0.143000 | 4.27e-01 |
SHC MEDIATED CASCADE FGFR1 | 15 | 3.40e-01 | -0.142000 | 7.02e-01 |
METALLOPROTEASE DUBS | 26 | 2.10e-01 | -0.142000 | 5.85e-01 |
DEADENYLATION DEPENDENT MRNA DECAY | 55 | 6.85e-02 | 0.142000 | 3.48e-01 |
INTERLEUKIN 6 SIGNALING | 10 | 4.37e-01 | -0.142000 | 7.74e-01 |
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 4.39e-01 | -0.141000 | 7.74e-01 |
SIGNAL TRANSDUCTION BY L1 | 21 | 2.63e-01 | 0.141000 | 6.47e-01 |
APC CDC20 MEDIATED DEGRADATION OF NEK2A | 25 | 2.24e-01 | 0.141000 | 6.05e-01 |
PHASE 2 PLATEAU PHASE | 13 | 3.80e-01 | 0.141000 | 7.34e-01 |
TRANSMISSION ACROSS CHEMICAL SYNAPSES | 236 | 2.07e-04 | 0.140000 | 1.72e-02 |
EUKARYOTIC TRANSLATION INITIATION | 115 | 9.38e-03 | -0.140000 | 1.37e-01 |
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 1.85e-01 | -0.140000 | 5.44e-01 |
LYSINE CATABOLISM | 11 | 4.22e-01 | -0.140000 | 7.62e-01 |
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 1.59e-01 | -0.140000 | 5.08e-01 |
GLYCOGEN STORAGE DISEASES | 12 | 4.03e-01 | -0.140000 | 7.51e-01 |
ACTIVATION OF BH3 ONLY PROTEINS | 30 | 1.89e-01 | 0.139000 | 5.51e-01 |
GPVI MEDIATED ACTIVATION CASCADE | 31 | 1.84e-01 | -0.138000 | 5.44e-01 |
OPIOID SIGNALLING | 85 | 2.89e-02 | 0.137000 | 2.40e-01 |
REGULATION OF INSULIN SECRETION | 70 | 4.77e-02 | 0.137000 | 2.99e-01 |
G2 M DNA DAMAGE CHECKPOINT | 67 | 5.33e-02 | -0.137000 | 3.09e-01 |
G0 AND EARLY G1 | 25 | 2.38e-01 | -0.136000 | 6.28e-01 |
INTERLEUKIN 6 FAMILY SIGNALING | 19 | 3.04e-01 | -0.136000 | 6.86e-01 |
NUCLEOTIDE EXCISION REPAIR | 110 | 1.37e-02 | 0.136000 | 1.63e-01 |
INHIBITION OF DNA RECOMBINATION AT TELOMERE | 36 | 1.58e-01 | -0.136000 | 5.07e-01 |
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 2.09e-01 | 0.135000 | 5.85e-01 |
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 1.05e-01 | 0.134000 | 4.27e-01 |
DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 4.07e-01 | 0.133000 | 7.51e-01 |
RHOC GTPASE CYCLE | 73 | 5.06e-02 | -0.132000 | 3.09e-01 |
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 4.36e-02 | 0.132000 | 2.94e-01 |
SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 2.95e-01 | -0.132000 | 6.77e-01 |
MRNA CAPPING | 29 | 2.19e-01 | 0.132000 | 5.97e-01 |
DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 2.07e-01 | -0.131000 | 5.82e-01 |
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 25 | 2.57e-01 | -0.131000 | 6.43e-01 |
PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 3.65e-01 | 0.131000 | 7.27e-01 |
SIGNALING BY NTRK2 TRKB | 24 | 2.70e-01 | 0.130000 | 6.52e-01 |
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 3.27e-01 | 0.130000 | 6.94e-01 |
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 42 | 1.45e-01 | -0.130000 | 4.91e-01 |
MITOTIC TELOPHASE CYTOKINESIS | 13 | 4.18e-01 | -0.130000 | 7.60e-01 |
INTEGRIN CELL SURFACE INTERACTIONS | 68 | 6.49e-02 | -0.129000 | 3.38e-01 |
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 4.19e-01 | -0.129000 | 7.60e-01 |
REPRESSION OF WNT TARGET GENES | 14 | 4.02e-01 | -0.129000 | 7.51e-01 |
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 3.87e-01 | -0.129000 | 7.42e-01 |
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 4.14e-02 | 0.129000 | 2.89e-01 |
GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 3.89e-01 | -0.129000 | 7.42e-01 |
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 73 | 5.95e-02 | -0.128000 | 3.30e-01 |
NEUTROPHIL DEGRANULATION | 390 | 1.64e-05 | -0.127000 | 3.18e-03 |
ION TRANSPORT BY P TYPE ATPASES | 47 | 1.31e-01 | 0.127000 | 4.72e-01 |
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 1.93e-01 | -0.127000 | 5.54e-01 |
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 3.51e-01 | -0.127000 | 7.13e-01 |
SENSORY PROCESSING OF SOUND | 61 | 8.87e-02 | 0.126000 | 3.97e-01 |
NONSENSE MEDIATED DECAY NMD | 110 | 2.28e-02 | -0.126000 | 2.14e-01 |
TRNA PROCESSING IN THE NUCLEUS | 56 | 1.04e-01 | 0.126000 | 4.27e-01 |
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 2.51e-01 | 0.125000 | 6.35e-01 |
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 4.60e-02 | 0.125000 | 2.98e-01 |
INTEGRATION OF ENERGY METABOLISM | 96 | 3.42e-02 | 0.125000 | 2.56e-01 |
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 2.11e-01 | 0.124000 | 5.85e-01 |
GENERATION OF SECOND MESSENGER MOLECULES | 18 | 3.62e-01 | -0.124000 | 7.24e-01 |
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 3.63e-01 | -0.124000 | 7.24e-01 |
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 4.59e-01 | -0.124000 | 7.88e-01 |
APOPTOTIC EXECUTION PHASE | 45 | 1.52e-01 | -0.124000 | 5.00e-01 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 2.42e-01 | 0.123000 | 6.30e-01 |
SNRNP ASSEMBLY | 51 | 1.27e-01 | 0.123000 | 4.69e-01 |
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 3.93e-01 | 0.123000 | 7.47e-01 |
NOD1 2 SIGNALING PATHWAY | 34 | 2.14e-01 | -0.123000 | 5.90e-01 |
CHAPERONE MEDIATED AUTOPHAGY | 20 | 3.44e-01 | -0.122000 | 7.04e-01 |
SIGNALING BY FLT3 FUSION PROTEINS | 18 | 3.70e-01 | -0.122000 | 7.29e-01 |
ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 4.83e-01 | -0.122000 | 7.96e-01 |
IRAK1 RECRUITS IKK COMPLEX | 14 | 4.29e-01 | -0.122000 | 7.70e-01 |
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 28 | 2.65e-01 | 0.122000 | 6.48e-01 |
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 51 | 1.33e-01 | -0.122000 | 4.75e-01 |
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 1.46e-01 | 0.121000 | 4.91e-01 |
NEGATIVE REGULATION OF MAPK PATHWAY | 43 | 1.70e-01 | 0.121000 | 5.26e-01 |
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 6.40e-02 | 0.121000 | 3.38e-01 |
RND1 GTPASE CYCLE | 38 | 1.99e-01 | -0.121000 | 5.64e-01 |
FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 2.98e-01 | -0.120000 | 6.78e-01 |
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 2.89e-01 | 0.120000 | 6.70e-01 |
CARDIAC CONDUCTION | 108 | 3.10e-02 | 0.120000 | 2.42e-01 |
STRIATED MUSCLE CONTRACTION | 24 | 3.08e-01 | 0.120000 | 6.89e-01 |
CS DS DEGRADATION | 14 | 4.37e-01 | 0.120000 | 7.74e-01 |
FCGR3A MEDIATED IL10 SYNTHESIS | 33 | 2.34e-01 | -0.120000 | 6.24e-01 |
SEMA4D IN SEMAPHORIN SIGNALING | 24 | 3.11e-01 | -0.120000 | 6.90e-01 |
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 64 | 9.86e-02 | -0.119000 | 4.19e-01 |
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 3.05e-01 | -0.119000 | 6.88e-01 |
FRS MEDIATED FGFR1 SIGNALING | 17 | 3.99e-01 | -0.118000 | 7.51e-01 |
GAB1 SIGNALOSOME | 14 | 4.44e-01 | -0.118000 | 7.76e-01 |
MEIOTIC SYNAPSIS | 41 | 1.95e-01 | -0.117000 | 5.57e-01 |
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 17 | 4.04e-01 | 0.117000 | 7.51e-01 |
HEME SIGNALING | 44 | 1.80e-01 | 0.117000 | 5.38e-01 |
SIGNALING BY RETINOIC ACID | 34 | 2.41e-01 | -0.116000 | 6.29e-01 |
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 4.52e-01 | -0.116000 | 7.83e-01 |
SIGNALING BY NTRK3 TRKC | 17 | 4.07e-01 | 0.116000 | 7.51e-01 |
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 3.37e-01 | 0.116000 | 6.99e-01 |
VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 3.85e-01 | -0.115000 | 7.42e-01 |
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 20 | 3.73e-01 | 0.115000 | 7.29e-01 |
G PROTEIN MEDIATED EVENTS | 51 | 1.57e-01 | 0.115000 | 5.07e-01 |
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 8.46e-02 | 0.114000 | 3.89e-01 |
METABOLISM OF CARBOHYDRATES | 257 | 1.63e-03 | 0.114000 | 4.76e-02 |
SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 4.76e-01 | -0.114000 | 7.90e-01 |
EPH EPHRIN MEDIATED REPULSION OF CELLS | 49 | 1.69e-01 | 0.114000 | 5.26e-01 |
DNA DAMAGE BYPASS | 48 | 1.74e-01 | 0.113000 | 5.31e-01 |
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 168 | 1.16e-02 | 0.113000 | 1.46e-01 |
DAP12 SIGNALING | 24 | 3.39e-01 | -0.113000 | 7.01e-01 |
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 62 | 1.26e-01 | -0.112000 | 4.69e-01 |
PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 4.66e-01 | 0.112000 | 7.88e-01 |
SIGNALING BY NUCLEAR RECEPTORS | 224 | 3.83e-03 | -0.112000 | 8.57e-02 |
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 77 | 8.86e-02 | -0.112000 | 3.97e-01 |
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 6.34e-02 | -0.112000 | 3.38e-01 |
INFLUENZA INFECTION | 146 | 1.98e-02 | -0.112000 | 2.02e-01 |
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 1.39e-01 | -0.111000 | 4.88e-01 |
PROLACTIN RECEPTOR SIGNALING | 12 | 5.05e-01 | -0.111000 | 8.07e-01 |
CYTOKINE SIGNALING IN IMMUNE SYSTEM | 547 | 9.74e-06 | -0.111000 | 3.18e-03 |
VITAMIN B5 PANTOTHENATE METABOLISM | 15 | 4.61e-01 | -0.110000 | 7.88e-01 |
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 34 | 2.67e-01 | 0.110000 | 6.51e-01 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.28e-01 | 0.109000 | 4.69e-01 |
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 2.10e-01 | 0.109000 | 5.85e-01 |
NUCLEOBASE CATABOLISM | 31 | 2.95e-01 | 0.109000 | 6.77e-01 |
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 4.98e-01 | -0.109000 | 8.06e-01 |
PI 3K CASCADE FGFR1 | 15 | 4.67e-01 | -0.109000 | 7.88e-01 |
MEIOSIS | 64 | 1.34e-01 | -0.108000 | 4.76e-01 |
LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 2.97e-01 | 0.108000 | 6.78e-01 |
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 1.44e-01 | 0.108000 | 4.91e-01 |
ESR MEDIATED SIGNALING | 165 | 1.72e-02 | -0.108000 | 1.91e-01 |
NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 3.35e-01 | 0.107000 | 6.97e-01 |
AUTOPHAGY | 138 | 3.01e-02 | 0.107000 | 2.42e-01 |
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 8.65e-02 | 0.107000 | 3.95e-01 |
PLATELET CALCIUM HOMEOSTASIS | 25 | 3.55e-01 | 0.107000 | 7.19e-01 |
DOWNREGULATION OF ERBB2 SIGNALING | 28 | 3.31e-01 | -0.106000 | 6.94e-01 |
CELL JUNCTION ORGANIZATION | 73 | 1.17e-01 | -0.106000 | 4.54e-01 |
NEDDYLATION | 217 | 7.74e-03 | 0.105000 | 1.26e-01 |
LAMININ INTERACTIONS | 27 | 3.46e-01 | -0.105000 | 7.06e-01 |
FATTY ACID METABOLISM | 144 | 3.02e-02 | -0.105000 | 2.42e-01 |
INWARDLY RECTIFYING K CHANNELS | 31 | 3.15e-01 | 0.104000 | 6.92e-01 |
SIGNALING BY TGFB FAMILY MEMBERS | 97 | 7.69e-02 | -0.104000 | 3.65e-01 |
INTERLEUKIN 20 FAMILY SIGNALING | 14 | 5.01e-01 | 0.104000 | 8.06e-01 |
EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 1.42e-01 | -0.104000 | 4.88e-01 |
RHOQ GTPASE CYCLE | 58 | 1.73e-01 | -0.103000 | 5.31e-01 |
PEXOPHAGY | 11 | 5.54e-01 | 0.103000 | 8.32e-01 |
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 48 | 2.18e-01 | -0.103000 | 5.93e-01 |
P75NTR SIGNALS VIA NF KB | 16 | 4.76e-01 | -0.103000 | 7.90e-01 |
TRANSLESION SYNTHESIS BY POLH | 19 | 4.38e-01 | 0.103000 | 7.74e-01 |
TOLL LIKE RECEPTOR CASCADES | 137 | 3.83e-02 | -0.103000 | 2.74e-01 |
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 4.92e-01 | -0.102000 | 8.01e-01 |
SARS COV 2 INFECTION | 65 | 1.55e-01 | 0.102000 | 5.05e-01 |
MITOPHAGY | 29 | 3.44e-01 | 0.102000 | 7.04e-01 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 4.32e-01 | -0.101000 | 7.74e-01 |
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 179 | 1.94e-02 | -0.101000 | 2.02e-01 |
NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 32 | 3.21e-01 | 0.101000 | 6.93e-01 |
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 3.64e-01 | 0.101000 | 7.26e-01 |
NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.89e-01 | 0.101000 | 6.70e-01 |
MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 4.25e-01 | 0.101000 | 7.66e-01 |
REGULATED NECROSIS | 46 | 2.39e-01 | -0.100000 | 6.29e-01 |
GOLGI TO ER RETROGRADE TRANSPORT | 119 | 5.86e-02 | 0.100000 | 3.28e-01 |
PYRIMIDINE CATABOLISM | 10 | 5.84e-01 | 0.100000 | 8.41e-01 |
NRAGE SIGNALS DEATH THROUGH JNK | 56 | 1.95e-01 | 0.100000 | 5.57e-01 |
SIGNALING BY SCF KIT | 41 | 2.69e-01 | -0.099900 | 6.51e-01 |
HYALURONAN METABOLISM | 15 | 5.04e-01 | 0.099500 | 8.07e-01 |
SUMOYLATION OF RNA BINDING PROTEINS | 45 | 2.49e-01 | 0.099400 | 6.35e-01 |
LYSOSOME VESICLE BIOGENESIS | 33 | 3.25e-01 | 0.099100 | 6.94e-01 |
SULFUR AMINO ACID METABOLISM | 23 | 4.11e-01 | -0.099000 | 7.52e-01 |
IRS MEDIATED SIGNALLING | 37 | 2.99e-01 | -0.098800 | 6.78e-01 |
NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 4.04e-01 | 0.098400 | 7.51e-01 |
SIGNALING BY NTRKS | 130 | 5.32e-02 | 0.098300 | 3.09e-01 |
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 4.15e-01 | -0.098200 | 7.55e-01 |
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 4.47e-01 | 0.098200 | 7.79e-01 |
ION CHANNEL TRANSPORT | 139 | 4.60e-02 | 0.098100 | 2.98e-01 |
AGGREPHAGY | 35 | 3.17e-01 | 0.097800 | 6.92e-01 |
AURKA ACTIVATION BY TPX2 | 71 | 1.56e-01 | 0.097500 | 5.06e-01 |
SIGNALING BY ACTIVIN | 12 | 5.60e-01 | -0.097100 | 8.34e-01 |
REPRODUCTION | 74 | 1.49e-01 | -0.097100 | 4.96e-01 |
RHOF GTPASE CYCLE | 40 | 2.88e-01 | -0.097000 | 6.70e-01 |
PARASITE INFECTION | 56 | 2.10e-01 | 0.096900 | 5.85e-01 |
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 4.54e-01 | 0.096800 | 7.84e-01 |
CLATHRIN MEDIATED ENDOCYTOSIS | 134 | 5.33e-02 | 0.096700 | 3.09e-01 |
REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 5.79e-01 | -0.096700 | 8.41e-01 |
RHOG GTPASE CYCLE | 73 | 1.55e-01 | -0.096400 | 5.05e-01 |
E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 4.68e-01 | -0.096200 | 7.88e-01 |
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 41 | 2.87e-01 | -0.096000 | 6.70e-01 |
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 4.48e-01 | -0.095700 | 7.79e-01 |
DISEASES OF CARBOHYDRATE METABOLISM | 29 | 3.73e-01 | 0.095700 | 7.29e-01 |
SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.42e-01 | 0.095600 | 7.02e-01 |
BASIGIN INTERACTIONS | 22 | 4.38e-01 | -0.095500 | 7.74e-01 |
EPH EPHRIN SIGNALING | 90 | 1.21e-01 | 0.094700 | 4.61e-01 |
NR1H2 AND NR1H3 MEDIATED SIGNALING | 39 | 3.07e-01 | -0.094500 | 6.89e-01 |
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 285 | 6.40e-03 | 0.094000 | 1.24e-01 |
PEROXISOMAL PROTEIN IMPORT | 58 | 2.16e-01 | -0.094000 | 5.91e-01 |
RET SIGNALING | 37 | 3.24e-01 | 0.093700 | 6.93e-01 |
RHO GTPASES ACTIVATE IQGAPS | 23 | 4.39e-01 | 0.093200 | 7.74e-01 |
G ALPHA S SIGNALLING EVENTS | 104 | 1.01e-01 | 0.093000 | 4.26e-01 |
SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 3.28e-01 | 0.092900 | 6.94e-01 |
ZINC TRANSPORTERS | 15 | 5.34e-01 | 0.092800 | 8.23e-01 |
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 3.79e-01 | 0.092800 | 7.33e-01 |
INTERLEUKIN 12 FAMILY SIGNALING | 43 | 2.94e-01 | -0.092500 | 6.77e-01 |
CARNITINE METABOLISM | 14 | 5.49e-01 | -0.092500 | 8.30e-01 |
PHOSPHORYLATION OF THE APC C | 17 | 5.09e-01 | 0.092400 | 8.09e-01 |
INNATE IMMUNE SYSTEM | 781 | 1.37e-05 | -0.092000 | 3.18e-03 |
PLATELET HOMEOSTASIS | 77 | 1.64e-01 | 0.091800 | 5.16e-01 |
INTEGRIN SIGNALING | 24 | 4.37e-01 | -0.091600 | 7.74e-01 |
REGULATION OF IFNA SIGNALING | 12 | 5.83e-01 | -0.091600 | 8.41e-01 |
DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 5.53e-01 | 0.091500 | 8.32e-01 |
NUCLEAR IMPORT OF REV PROTEIN | 32 | 3.72e-01 | 0.091200 | 7.29e-01 |
ASPARAGINE N LINKED GLYCOSYLATION | 281 | 8.78e-03 | 0.091000 | 1.31e-01 |
MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 3.76e-01 | -0.090500 | 7.29e-01 |
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 2.31e-01 | -0.090200 | 6.19e-01 |
MHC CLASS II ANTIGEN PRESENTATION | 103 | 1.14e-01 | 0.090200 | 4.49e-01 |
NEGATIVE REGULATION OF FLT3 | 14 | 5.60e-01 | 0.090100 | 8.34e-01 |
SIGNALLING TO RAS | 19 | 4.98e-01 | -0.089700 | 8.06e-01 |
C TYPE LECTIN RECEPTORS CLRS | 112 | 1.05e-01 | -0.088800 | 4.27e-01 |
RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.09e-01 | -0.088700 | 7.51e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 5.04e-01 | -0.088500 | 8.07e-01 |
NICOTINAMIDE SALVAGING | 16 | 5.40e-01 | 0.088500 | 8.27e-01 |
NEGATIVE REGULATION OF FGFR4 SIGNALING | 22 | 4.75e-01 | 0.088000 | 7.90e-01 |
PYRIMIDINE SALVAGE | 10 | 6.31e-01 | 0.087600 | 8.71e-01 |
METABOLISM OF COFACTORS | 18 | 5.20e-01 | -0.087600 | 8.17e-01 |
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 3.99e-01 | 0.087500 | 7.51e-01 |
DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 4.99e-01 | -0.087400 | 8.06e-01 |
RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 4.68e-01 | 0.087400 | 7.88e-01 |
NUCLEAR SIGNALING BY ERBB4 | 31 | 4.00e-01 | -0.087300 | 7.51e-01 |
SYNDECAN INTERACTIONS | 26 | 4.41e-01 | -0.087300 | 7.76e-01 |
MUSCLE CONTRACTION | 159 | 5.86e-02 | 0.087000 | 3.28e-01 |
KERATAN SULFATE KERATIN METABOLISM | 30 | 4.10e-01 | 0.087000 | 7.51e-01 |
SUMOYLATION OF DNA METHYLATION PROTEINS | 15 | 5.60e-01 | 0.086900 | 8.34e-01 |
RAC2 GTPASE CYCLE | 86 | 1.64e-01 | -0.086900 | 5.16e-01 |
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 6.18e-01 | -0.086800 | 8.65e-01 |
FCERI MEDIATED MAPK ACTIVATION | 28 | 4.27e-01 | -0.086800 | 7.67e-01 |
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 2.50e-01 | 0.086700 | 6.35e-01 |
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 2.37e-01 | 0.086200 | 6.28e-01 |
P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.91e-01 | -0.086100 | 8.46e-01 |
NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 2.77e-01 | 0.085600 | 6.59e-01 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 6.23e-01 | -0.085500 | 8.67e-01 |
METHYLATION | 12 | 6.08e-01 | -0.085400 | 8.57e-01 |
SIGNALING BY PTK6 | 51 | 2.92e-01 | -0.085300 | 6.76e-01 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 50 | 2.97e-01 | 0.085200 | 6.78e-01 |
GROWTH HORMONE RECEPTOR SIGNALING | 21 | 5.01e-01 | -0.084800 | 8.06e-01 |
TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 4.07e-01 | 0.084800 | 7.51e-01 |
PIWI INTERACTING RNA PIRNA BIOGENESIS | 22 | 4.93e-01 | 0.084500 | 8.01e-01 |
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 3.62e-01 | 0.084400 | 7.24e-01 |
SIGNALING BY INTERLEUKINS | 349 | 6.97e-03 | -0.084300 | 1.24e-01 |
FATTY ACYL COA BIOSYNTHESIS | 32 | 4.10e-01 | -0.084200 | 7.51e-01 |
RHOH GTPASE CYCLE | 37 | 3.76e-01 | -0.084200 | 7.29e-01 |
INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 5.15e-01 | -0.084100 | 8.16e-01 |
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 5.28e-01 | 0.083700 | 8.22e-01 |
NEUROTRANSMITTER RELEASE CYCLE | 48 | 3.19e-01 | 0.083200 | 6.92e-01 |
MET RECEPTOR RECYCLING | 10 | 6.49e-01 | -0.083100 | 8.80e-01 |
SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 3.46e-01 | 0.083000 | 7.06e-01 |
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 3.58e-01 | 0.083000 | 7.21e-01 |
RAF ACTIVATION | 34 | 4.03e-01 | 0.082800 | 7.51e-01 |
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 5.33e-01 | -0.082600 | 8.23e-01 |
PROTEIN FOLDING | 87 | 1.84e-01 | 0.082500 | 5.44e-01 |
REGULATION OF EXPRESSION OF SLITS AND ROBOS | 162 | 7.04e-02 | -0.082500 | 3.55e-01 |
ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 4.44e-01 | -0.082100 | 7.76e-01 |
RNA POLYMERASE I PROMOTER ESCAPE | 48 | 3.28e-01 | -0.081700 | 6.94e-01 |
GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 6.11e-01 | -0.081600 | 8.58e-01 |
BILE ACID AND BILE SALT METABOLISM | 25 | 4.81e-01 | -0.081500 | 7.94e-01 |
PROTEIN METHYLATION | 17 | 5.61e-01 | -0.081500 | 8.34e-01 |
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 5.29e-01 | -0.081400 | 8.22e-01 |
TRANSLESION SYNTHESIS BY POLK | 17 | 5.62e-01 | 0.081300 | 8.34e-01 |
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 90 | 1.83e-01 | -0.081200 | 5.44e-01 |
SPHINGOLIPID METABOLISM | 79 | 2.13e-01 | -0.081000 | 5.89e-01 |
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 5.52e-01 | -0.081000 | 8.32e-01 |
GAP JUNCTION DEGRADATION | 11 | 6.42e-01 | 0.080900 | 8.76e-01 |
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 5.04e-01 | -0.080500 | 8.07e-01 |
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 4.62e-01 | 0.080400 | 7.88e-01 |
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 33 | 4.26e-01 | -0.080100 | 7.66e-01 |
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 4.00e-01 | 0.079900 | 7.51e-01 |
DISEASES OF GLYCOSYLATION | 122 | 1.28e-01 | 0.079800 | 4.69e-01 |
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.91e-01 | 0.079600 | 8.01e-01 |
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 67 | 2.61e-01 | -0.079500 | 6.43e-01 |
TRANSLATION | 287 | 2.09e-02 | -0.079400 | 2.06e-01 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 6.20e-01 | 0.079300 | 8.67e-01 |
CELLULAR RESPONSE TO HEAT STRESS | 96 | 1.80e-01 | -0.079200 | 5.38e-01 |
TIE2 SIGNALING | 17 | 5.72e-01 | -0.079100 | 8.38e-01 |
TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 4.25e-01 | -0.079000 | 7.66e-01 |
DNA STRAND ELONGATION | 32 | 4.42e-01 | 0.078500 | 7.76e-01 |
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 4.89e-01 | 0.078400 | 8.01e-01 |
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 6.00e-01 | 0.078300 | 8.53e-01 |
KILLING MECHANISMS | 10 | 6.69e-01 | 0.078200 | 8.86e-01 |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 311 | 1.87e-02 | -0.077700 | 1.99e-01 |
HIV LIFE CYCLE | 143 | 1.10e-01 | 0.077400 | 4.37e-01 |
SELECTIVE AUTOPHAGY | 72 | 2.59e-01 | 0.076900 | 6.43e-01 |
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 4.52e-01 | -0.076900 | 7.83e-01 |
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 14 | 6.19e-01 | -0.076900 | 8.65e-01 |
PI METABOLISM | 79 | 2.40e-01 | 0.076400 | 6.29e-01 |
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 5.67e-01 | 0.075900 | 8.36e-01 |
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 60 | 3.09e-01 | -0.075900 | 6.89e-01 |
RHOJ GTPASE CYCLE | 54 | 3.36e-01 | -0.075700 | 6.98e-01 |
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 6.65e-01 | -0.075500 | 8.86e-01 |
SIGNALING BY ERBB2 | 48 | 3.66e-01 | -0.075400 | 7.27e-01 |
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 5.80e-01 | 0.075300 | 8.41e-01 |
MYD88 INDEPENDENT TLR4 CASCADE | 93 | 2.11e-01 | -0.075100 | 5.85e-01 |
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 11 | 6.67e-01 | -0.074900 | 8.86e-01 |
TRIGLYCERIDE METABOLISM | 22 | 5.44e-01 | -0.074800 | 8.27e-01 |
CRISTAE FORMATION | 31 | 4.71e-01 | -0.074800 | 7.88e-01 |
ASPARTATE AND ASPARAGINE METABOLISM | 11 | 6.68e-01 | 0.074700 | 8.86e-01 |
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 3.66e-01 | -0.074700 | 7.27e-01 |
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 2.57e-01 | 0.074700 | 6.43e-01 |
CHROMOSOME MAINTENANCE | 103 | 1.91e-01 | -0.074600 | 5.51e-01 |
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 3.30e-01 | 0.074000 | 6.94e-01 |
BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 5.60e-01 | -0.073500 | 8.34e-01 |
TELOMERE MAINTENANCE | 79 | 2.60e-01 | -0.073300 | 6.43e-01 |
REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 3.30e-01 | 0.073300 | 6.94e-01 |
INSULIN PROCESSING | 24 | 5.36e-01 | 0.073000 | 8.25e-01 |
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 4.63e-01 | 0.072700 | 7.88e-01 |
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 3.16e-01 | 0.072500 | 6.92e-01 |
G2 M CHECKPOINTS | 135 | 1.47e-01 | -0.072400 | 4.91e-01 |
AQUAPORIN MEDIATED TRANSPORT | 39 | 4.36e-01 | 0.072100 | 7.74e-01 |
LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 6.66e-01 | -0.072000 | 8.86e-01 |
TRNA AMINOACYLATION | 42 | 4.20e-01 | 0.072000 | 7.60e-01 |
SYNTHESIS OF PC | 26 | 5.29e-01 | -0.071400 | 8.22e-01 |
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 4.72e-01 | -0.071300 | 7.88e-01 |
KERATAN SULFATE BIOSYNTHESIS | 24 | 5.46e-01 | 0.071300 | 8.28e-01 |
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 12 | 6.69e-01 | -0.071200 | 8.86e-01 |
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 5.31e-01 | -0.070900 | 8.22e-01 |
CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 5.83e-01 | 0.070900 | 8.41e-01 |
PINK1 PRKN MEDIATED MITOPHAGY | 22 | 5.65e-01 | 0.070900 | 8.35e-01 |
PI3K AKT SIGNALING IN CANCER | 89 | 2.49e-01 | -0.070800 | 6.35e-01 |
RHOA GTPASE CYCLE | 143 | 1.45e-01 | -0.070600 | 4.91e-01 |
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 94 | 2.37e-01 | 0.070600 | 6.28e-01 |
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 3.72e-01 | 0.070300 | 7.29e-01 |
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 5.44e-01 | 0.070200 | 8.27e-01 |
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 6.40e-01 | 0.069800 | 8.76e-01 |
MET PROMOTES CELL MOTILITY | 39 | 4.51e-01 | -0.069800 | 7.83e-01 |
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 1.02e-01 | 0.069700 | 4.27e-01 |
BASE EXCISION REPAIR AP SITE FORMATION | 30 | 5.09e-01 | -0.069700 | 8.09e-01 |
NICOTINATE METABOLISM | 26 | 5.42e-01 | 0.069100 | 8.27e-01 |
INTERLEUKIN 12 SIGNALING | 37 | 4.68e-01 | -0.068900 | 7.88e-01 |
TRANSCRIPTION OF THE HIV GENOME | 67 | 3.31e-01 | 0.068700 | 6.94e-01 |
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.87e-01 | -0.068400 | 5.48e-01 |
UB SPECIFIC PROCESSING PROTEASES | 168 | 1.27e-01 | -0.068300 | 4.69e-01 |
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 4.86e-01 | 0.068000 | 7.98e-01 |
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 83 | 2.85e-01 | 0.067900 | 6.70e-01 |
SMOOTH MUSCLE CONTRACTION | 32 | 5.07e-01 | -0.067800 | 8.08e-01 |
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 12 | 6.85e-01 | -0.067600 | 8.98e-01 |
RNA POLYMERASE III TRANSCRIPTION | 41 | 4.57e-01 | 0.067100 | 7.88e-01 |
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 3.74e-01 | 0.067000 | 7.29e-01 |
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 13 | 6.76e-01 | -0.066900 | 8.92e-01 |
CELLULAR RESPONSE TO STARVATION | 146 | 1.64e-01 | -0.066900 | 5.16e-01 |
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 33 | 5.07e-01 | -0.066700 | 8.08e-01 |
PCP CE PATHWAY | 89 | 2.78e-01 | 0.066600 | 6.59e-01 |
SIGNAL AMPLIFICATION | 29 | 5.38e-01 | -0.066000 | 8.26e-01 |
REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 4.99e-01 | -0.066000 | 8.06e-01 |
DNA DOUBLE STRAND BREAK RESPONSE | 53 | 4.07e-01 | -0.065900 | 7.51e-01 |
SIGNALING BY WNT IN CANCER | 31 | 5.27e-01 | -0.065700 | 8.22e-01 |
ASSEMBLY OF THE HIV VIRION | 16 | 6.49e-01 | 0.065700 | 8.80e-01 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.06e-01 | -0.065700 | 9.09e-01 |
OXIDATIVE STRESS INDUCED SENESCENCE | 79 | 3.13e-01 | -0.065600 | 6.92e-01 |
SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 3.41e-01 | -0.064900 | 7.02e-01 |
EPHB MEDIATED FORWARD SIGNALING | 42 | 4.67e-01 | 0.064800 | 7.88e-01 |
CLEC7A DECTIN 1 SIGNALING | 93 | 2.80e-01 | -0.064800 | 6.65e-01 |
MEMBRANE TRAFFICKING | 579 | 7.95e-03 | 0.064800 | 1.26e-01 |
REGULATION OF BETA CELL DEVELOPMENT | 25 | 5.76e-01 | -0.064700 | 8.40e-01 |
MRNA SPLICING | 188 | 1.27e-01 | 0.064600 | 4.69e-01 |
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 8.79e-02 | 0.064400 | 3.97e-01 |
GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 5.48e-01 | 0.064400 | 8.30e-01 |
DNA REPAIR | 295 | 5.90e-02 | 0.064000 | 3.29e-01 |
G ALPHA I SIGNALLING EVENTS | 193 | 1.26e-01 | 0.063900 | 4.69e-01 |
COPII MEDIATED VESICLE TRANSPORT | 65 | 3.77e-01 | 0.063400 | 7.30e-01 |
HIV INFECTION | 222 | 1.05e-01 | 0.063200 | 4.27e-01 |
COMPLEX I BIOGENESIS | 56 | 4.14e-01 | -0.063100 | 7.55e-01 |
NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 5.64e-01 | -0.063000 | 8.35e-01 |
SIGNALING BY WNT | 267 | 7.82e-02 | -0.062700 | 3.69e-01 |
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 85 | 3.19e-01 | 0.062600 | 6.92e-01 |
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 11 | 7.20e-01 | -0.062500 | 9.15e-01 |
TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 5.83e-01 | 0.062200 | 8.41e-01 |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 105 | 2.73e-01 | -0.061900 | 6.55e-01 |
RHOD GTPASE CYCLE | 49 | 4.54e-01 | 0.061800 | 7.84e-01 |
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 4.85e-01 | -0.061500 | 7.98e-01 |
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 5.54e-01 | -0.061500 | 8.32e-01 |
RND3 GTPASE CYCLE | 38 | 5.16e-01 | -0.060900 | 8.16e-01 |
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 6.30e-01 | 0.060800 | 8.71e-01 |
COSTIMULATION BY THE CD28 FAMILY | 49 | 4.62e-01 | -0.060800 | 7.88e-01 |
WNT LIGAND BIOGENESIS AND TRAFFICKING | 20 | 6.40e-01 | 0.060400 | 8.76e-01 |
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 5.89e-01 | -0.060100 | 8.46e-01 |
COLLAGEN CHAIN TRIMERIZATION | 39 | 5.17e-01 | 0.060000 | 8.16e-01 |
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 4.72e-01 | -0.060000 | 7.88e-01 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 7.32e-01 | 0.059700 | 9.23e-01 |
RAB REGULATION OF TRAFFICKING | 117 | 2.66e-01 | 0.059600 | 6.48e-01 |
REGULATION OF LIPID METABOLISM BY PPARALPHA | 109 | 2.83e-01 | 0.059600 | 6.69e-01 |
BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 6.80e-01 | 0.059600 | 8.93e-01 |
ACYL CHAIN REMODELLING OF PE | 16 | 6.80e-01 | 0.059500 | 8.93e-01 |
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 7.01e-01 | 0.059200 | 9.07e-01 |
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 5.82e-01 | -0.059100 | 8.41e-01 |
HDMS DEMETHYLATE HISTONES | 28 | 5.89e-01 | -0.059000 | 8.46e-01 |
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 7.36e-01 | 0.058800 | 9.24e-01 |
CARGO CONCENTRATION IN THE ER | 30 | 5.78e-01 | -0.058700 | 8.41e-01 |
ARACHIDONIC ACID METABOLISM | 38 | 5.32e-01 | -0.058600 | 8.22e-01 |
MITOTIC G2 G2 M PHASES | 184 | 1.73e-01 | 0.058300 | 5.31e-01 |
NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 94 | 3.30e-01 | -0.058200 | 6.94e-01 |
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 5.19e-01 | -0.058200 | 8.17e-01 |
FANCONI ANEMIA PATHWAY | 36 | 5.47e-01 | 0.058000 | 8.29e-01 |
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 7.28e-01 | 0.058000 | 9.20e-01 |
RESPIRATORY ELECTRON TRANSPORT | 102 | 3.13e-01 | -0.057900 | 6.92e-01 |
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 6.32e-01 | 0.057600 | 8.71e-01 |
HATS ACETYLATE HISTONES | 93 | 3.38e-01 | 0.057500 | 7.00e-01 |
SIGNALING BY FGFR IN DISEASE | 55 | 4.62e-01 | -0.057300 | 7.88e-01 |
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 6.14e-01 | -0.057200 | 8.61e-01 |
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 6.23e-01 | 0.056800 | 8.67e-01 |
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 7.46e-01 | 0.056400 | 9.25e-01 |
INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 5.28e-01 | -0.056400 | 8.22e-01 |
DEUBIQUITINATION | 242 | 1.33e-01 | -0.056200 | 4.75e-01 |
TCR SIGNALING | 100 | 3.34e-01 | -0.055900 | 6.97e-01 |
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 5.46e-01 | 0.055900 | 8.28e-01 |
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 51 | 4.93e-01 | 0.055500 | 8.01e-01 |
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 37 | 5.60e-01 | 0.055400 | 8.34e-01 |
DISEASES OF MITOTIC CELL CYCLE | 37 | 5.62e-01 | 0.055100 | 8.34e-01 |
SIGNALING BY ERYTHROPOIETIN | 24 | 6.41e-01 | -0.055000 | 8.76e-01 |
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 4.15e-01 | 0.054800 | 7.55e-01 |
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 34 | 5.81e-01 | -0.054700 | 8.41e-01 |
VESICLE MEDIATED TRANSPORT | 609 | 2.19e-02 | 0.054600 | 2.10e-01 |
CITRIC ACID CYCLE TCA CYCLE | 22 | 6.58e-01 | 0.054600 | 8.86e-01 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 7.34e-01 | -0.054500 | 9.24e-01 |
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 24 | 6.45e-01 | 0.054300 | 8.77e-01 |
RHO GTPASES ACTIVATE PAKS | 21 | 6.68e-01 | 0.054100 | 8.86e-01 |
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 3.60e-01 | 0.054100 | 7.24e-01 |
CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 5.31e-01 | -0.054100 | 8.22e-01 |
OTHER SEMAPHORIN INTERACTIONS | 19 | 6.86e-01 | -0.053700 | 8.98e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 7.50e-01 | -0.053100 | 9.27e-01 |
INOSITOL PHOSPHATE METABOLISM | 47 | 5.29e-01 | 0.053100 | 8.22e-01 |
PLATELET AGGREGATION PLUG FORMATION | 33 | 5.99e-01 | -0.052900 | 8.53e-01 |
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 6.41e-01 | 0.052800 | 8.76e-01 |
RESOLUTION OF D LOOP STRUCTURES | 31 | 6.11e-01 | -0.052800 | 8.58e-01 |
INTERLEUKIN 1 FAMILY SIGNALING | 123 | 3.15e-01 | -0.052500 | 6.92e-01 |
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 6.09e-01 | -0.052300 | 8.57e-01 |
PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 6.94e-01 | 0.052200 | 9.04e-01 |
SIGNALING BY GPCR | 475 | 5.25e-02 | 0.052100 | 3.09e-01 |
SIGNALING BY ROBO RECEPTORS | 207 | 1.99e-01 | -0.051800 | 5.64e-01 |
GLUCAGON TYPE LIGAND RECEPTORS | 24 | 6.61e-01 | 0.051700 | 8.86e-01 |
HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.67e-01 | 0.051700 | 9.39e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 3.87e-01 | -0.051600 | 7.42e-01 |
G1 S DNA DAMAGE CHECKPOINTS | 65 | 4.72e-01 | -0.051600 | 7.88e-01 |
INTERLEUKIN 2 FAMILY SIGNALING | 34 | 6.03e-01 | -0.051500 | 8.54e-01 |
VISUAL PHOTOTRANSDUCTION | 61 | 4.87e-01 | -0.051500 | 7.98e-01 |
IRON UPTAKE AND TRANSPORT | 52 | 5.22e-01 | -0.051300 | 8.19e-01 |
CA2 PATHWAY | 55 | 5.14e-01 | -0.050900 | 8.15e-01 |
POLYMERASE SWITCHING | 14 | 7.42e-01 | 0.050800 | 9.25e-01 |
SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 5.71e-01 | 0.050600 | 8.38e-01 |
CELLULAR SENESCENCE | 143 | 2.98e-01 | -0.050500 | 6.78e-01 |
OTHER INTERLEUKIN SIGNALING | 20 | 6.99e-01 | 0.050000 | 9.06e-01 |
HOMOLOGY DIRECTED REPAIR | 110 | 3.69e-01 | -0.049600 | 7.29e-01 |
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 6.02e-01 | 0.049600 | 8.54e-01 |
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 91 | 4.15e-01 | 0.049500 | 7.55e-01 |
RMTS METHYLATE HISTONE ARGININES | 44 | 5.71e-01 | -0.049300 | 8.38e-01 |
RAS PROCESSING | 24 | 6.77e-01 | -0.049100 | 8.92e-01 |
HEDGEHOG ON STATE | 82 | 4.43e-01 | -0.049000 | 7.76e-01 |
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 7.43e-01 | 0.048900 | 9.25e-01 |
GLYCOSPHINGOLIPID METABOLISM | 38 | 6.02e-01 | 0.048900 | 8.54e-01 |
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.70e-01 | -0.048800 | 6.52e-01 |
LDL CLEARANCE | 16 | 7.37e-01 | 0.048600 | 9.24e-01 |
STIMULI SENSING CHANNELS | 75 | 4.71e-01 | 0.048200 | 7.88e-01 |
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 4.02e-01 | 0.047800 | 7.51e-01 |
RAC1 GTPASE CYCLE | 177 | 2.77e-01 | -0.047400 | 6.59e-01 |
GENE SILENCING BY RNA | 87 | 4.47e-01 | -0.047200 | 7.79e-01 |
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 6.77e-01 | 0.047200 | 8.92e-01 |
NON INTEGRIN MEMBRANE ECM INTERACTIONS | 56 | 5.43e-01 | -0.047000 | 8.27e-01 |
SIGNALING BY FGFR2 IN DISEASE | 36 | 6.27e-01 | -0.046800 | 8.69e-01 |
DEGRADATION OF THE EXTRACELLULAR MATRIX | 106 | 4.05e-01 | 0.046800 | 7.51e-01 |
SIGNALING BY NOTCH | 189 | 2.68e-01 | -0.046800 | 6.51e-01 |
METABOLISM OF NUCLEOTIDES | 92 | 4.38e-01 | 0.046800 | 7.74e-01 |
PHOSPHOLIPID METABOLISM | 187 | 2.71e-01 | 0.046800 | 6.52e-01 |
BASE EXCISION REPAIR | 58 | 5.38e-01 | 0.046700 | 8.26e-01 |
POLO LIKE KINASE MEDIATED EVENTS | 14 | 7.62e-01 | 0.046700 | 9.37e-01 |
TRP CHANNELS | 19 | 7.26e-01 | -0.046500 | 9.18e-01 |
REGULATION OF SIGNALING BY CBL | 22 | 7.06e-01 | -0.046500 | 9.09e-01 |
ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 7.72e-01 | 0.046500 | 9.43e-01 |
CELLULAR RESPONSES TO EXTERNAL STIMULI | 601 | 5.38e-02 | -0.046200 | 3.10e-01 |
ONCOGENIC MAPK SIGNALING | 77 | 4.83e-01 | 0.046200 | 7.96e-01 |
SIGNALLING TO ERKS | 33 | 6.47e-01 | -0.046000 | 8.79e-01 |
CILIUM ASSEMBLY | 189 | 2.76e-01 | 0.046000 | 6.59e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX1 | 177 | 2.92e-01 | -0.046000 | 6.76e-01 |
METABOLISM OF RNA | 645 | 4.75e-02 | 0.045900 | 2.99e-01 |
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 82 | 4.73e-01 | 0.045900 | 7.88e-01 |
MITOCHONDRIAL PROTEIN IMPORT | 63 | 5.30e-01 | 0.045800 | 8.22e-01 |
TNFR2 NON CANONICAL NF KB PATHWAY | 79 | 4.82e-01 | -0.045700 | 7.96e-01 |
G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 7.39e-01 | 0.045300 | 9.25e-01 |
DEGRADATION OF DVL | 55 | 5.62e-01 | 0.045200 | 8.34e-01 |
FC EPSILON RECEPTOR FCERI SIGNALING | 122 | 3.92e-01 | -0.044900 | 7.45e-01 |
RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 7.22e-01 | 0.044900 | 9.16e-01 |
SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 7.98e-01 | -0.044500 | 9.58e-01 |
RHO GTPASE CYCLE | 426 | 1.17e-01 | -0.044400 | 4.54e-01 |
G ALPHA 12 13 SIGNALLING EVENTS | 75 | 5.06e-01 | 0.044400 | 8.08e-01 |
ONCOGENE INDUCED SENESCENCE | 32 | 6.64e-01 | -0.044400 | 8.86e-01 |
TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 1.62e-01 | 0.044100 | 5.15e-01 |
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 5.44e-01 | -0.043600 | 8.27e-01 |
PROLONGED ERK ACTIVATION EVENTS | 14 | 7.79e-01 | 0.043400 | 9.47e-01 |
MITOTIC METAPHASE AND ANAPHASE | 208 | 2.85e-01 | 0.043100 | 6.70e-01 |
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 4.90e-01 | 0.043100 | 8.01e-01 |
ORGANELLE BIOGENESIS AND MAINTENANCE | 281 | 2.15e-01 | 0.043000 | 5.91e-01 |
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.46e-01 | -0.043000 | 9.25e-01 |
HOST INTERACTIONS OF HIV FACTORS | 126 | 4.06e-01 | 0.042900 | 7.51e-01 |
PLASMA LIPOPROTEIN CLEARANCE | 27 | 7.01e-01 | 0.042800 | 9.07e-01 |
P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 4.73e-01 | 0.042600 | 7.88e-01 |
METABOLISM OF STEROIDS | 112 | 4.38e-01 | -0.042500 | 7.74e-01 |
PRE NOTCH PROCESSING IN GOLGI | 17 | 7.62e-01 | 0.042400 | 9.37e-01 |
SIGNALING BY BRAF AND RAF FUSIONS | 60 | 5.72e-01 | 0.042200 | 8.38e-01 |
CYTOSOLIC TRNA AMINOACYLATION | 24 | 7.20e-01 | 0.042200 | 9.15e-01 |
TRANSPORT OF SMALL MOLECULES | 566 | 8.90e-02 | 0.042000 | 3.97e-01 |
G ALPHA Z SIGNALLING EVENTS | 45 | 6.28e-01 | 0.041800 | 8.69e-01 |
NERVOUS SYSTEM DEVELOPMENT | 545 | 1.01e-01 | 0.041200 | 4.26e-01 |
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 6.23e-01 | -0.041000 | 8.67e-01 |
DISEASES OF METABOLISM | 197 | 3.23e-01 | 0.040900 | 6.93e-01 |
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 7.58e-01 | 0.040900 | 9.35e-01 |
REGULATION OF TP53 ACTIVITY | 151 | 3.89e-01 | 0.040700 | 7.42e-01 |
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 82 | 5.25e-01 | 0.040600 | 8.22e-01 |
GABA B RECEPTOR ACTIVATION | 39 | 6.61e-01 | 0.040600 | 8.86e-01 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 23 | 7.36e-01 | -0.040600 | 9.24e-01 |
HDR THROUGH SINGLE STRAND ANNEALING SSA | 37 | 6.70e-01 | -0.040400 | 8.86e-01 |
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 49 | 6.25e-01 | -0.040300 | 8.68e-01 |
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 366 | 1.87e-01 | -0.040300 | 5.48e-01 |
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 5.93e-01 | -0.040300 | 8.47e-01 |
HEDGEHOG LIGAND BIOGENESIS | 61 | 5.90e-01 | -0.039900 | 8.46e-01 |
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 7.85e-01 | -0.039300 | 9.51e-01 |
SIGNALING BY KIT IN DISEASE | 20 | 7.61e-01 | -0.039200 | 9.37e-01 |
MITOTIC PROMETAPHASE | 178 | 3.71e-01 | 0.038900 | 7.29e-01 |
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 8.23e-01 | -0.038900 | 9.65e-01 |
SIGNALING BY FGFR4 | 32 | 7.06e-01 | -0.038600 | 9.09e-01 |
FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 7.34e-01 | 0.038400 | 9.24e-01 |
PERK REGULATES GENE EXPRESSION | 28 | 7.26e-01 | -0.038300 | 9.18e-01 |
ACTIVATION OF RAC1 | 13 | 8.11e-01 | -0.038300 | 9.62e-01 |
TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 62 | 6.04e-01 | -0.038100 | 8.54e-01 |
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 24 | 7.47e-01 | -0.038100 | 9.25e-01 |
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 5.73e-01 | 0.037900 | 8.38e-01 |
SLC TRANSPORTER DISORDERS | 68 | 5.92e-01 | 0.037600 | 8.47e-01 |
SIALIC ACID METABOLISM | 32 | 7.14e-01 | 0.037500 | 9.12e-01 |
O LINKED GLYCOSYLATION OF MUCINS | 41 | 6.78e-01 | 0.037400 | 8.92e-01 |
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 7.96e-01 | 0.037400 | 9.57e-01 |
DEVELOPMENTAL BIOLOGY | 808 | 7.78e-02 | 0.036700 | 3.68e-01 |
M PHASE | 342 | 2.47e-01 | 0.036500 | 6.35e-01 |
MITOCHONDRIAL BIOGENESIS | 92 | 5.51e-01 | 0.036000 | 8.32e-01 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 8.05e-01 | 0.035600 | 9.61e-01 |
CELL CELL JUNCTION ORGANIZATION | 48 | 6.70e-01 | -0.035600 | 8.86e-01 |
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 63 | 6.26e-01 | -0.035500 | 8.68e-01 |
METABOLISM OF FOLATE AND PTERINES | 15 | 8.12e-01 | 0.035500 | 9.62e-01 |
ABC FAMILY PROTEINS MEDIATED TRANSPORT | 94 | 5.55e-01 | 0.035300 | 8.32e-01 |
CELL CYCLE CHECKPOINTS | 245 | 3.48e-01 | -0.034800 | 7.09e-01 |
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.50e-01 | 0.034800 | 9.27e-01 |
SENSORY PERCEPTION | 151 | 4.64e-01 | -0.034500 | 7.88e-01 |
MITOCHONDRIAL TRANSLATION | 93 | 5.65e-01 | -0.034500 | 8.35e-01 |
GABA RECEPTOR ACTIVATION | 53 | 6.64e-01 | -0.034500 | 8.86e-01 |
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 8.36e-01 | 0.034500 | 9.70e-01 |
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 8.30e-01 | -0.034300 | 9.69e-01 |
SIGNALING BY NOTCH1 | 75 | 6.09e-01 | -0.034200 | 8.57e-01 |
METABOLISM OF POLYAMINES | 57 | 6.62e-01 | 0.033500 | 8.86e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 6.98e-01 | 0.033500 | 9.06e-01 |
APOPTOSIS | 164 | 4.63e-01 | -0.033300 | 7.88e-01 |
INTERLEUKIN 17 SIGNALING | 66 | 6.41e-01 | 0.033200 | 8.76e-01 |
RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 6.21e-01 | 0.033200 | 8.67e-01 |
FLT3 SIGNALING IN DISEASE | 27 | 7.66e-01 | -0.033100 | 9.39e-01 |
SARS COV INFECTIONS | 140 | 5.00e-01 | 0.033000 | 8.06e-01 |
TP53 REGULATES METABOLIC GENES | 85 | 6.01e-01 | -0.032800 | 8.54e-01 |
PREGNENOLONE BIOSYNTHESIS | 12 | 8.44e-01 | -0.032800 | 9.71e-01 |
EXTRACELLULAR MATRIX ORGANIZATION | 241 | 3.88e-01 | -0.032300 | 7.42e-01 |
GLUTATHIONE CONJUGATION | 29 | 7.64e-01 | -0.032200 | 9.38e-01 |
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 6.53e-01 | 0.032100 | 8.81e-01 |
DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 137 | 5.20e-01 | 0.031900 | 8.17e-01 |
HCMV INFECTION | 104 | 5.75e-01 | 0.031800 | 8.40e-01 |
CTLA4 INHIBITORY SIGNALING | 20 | 8.07e-01 | -0.031600 | 9.62e-01 |
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 6.50e-01 | 0.031400 | 8.80e-01 |
RORA ACTIVATES GENE EXPRESSION | 18 | 8.18e-01 | -0.031300 | 9.64e-01 |
MYOGENESIS | 24 | 7.91e-01 | 0.031300 | 9.54e-01 |
INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 6.97e-01 | 0.031200 | 9.06e-01 |
SIGNALING BY MET | 75 | 6.44e-01 | -0.030800 | 8.77e-01 |
DEATH RECEPTOR SIGNALLING | 134 | 5.38e-01 | 0.030800 | 8.26e-01 |
RND2 GTPASE CYCLE | 38 | 7.43e-01 | -0.030800 | 9.25e-01 |
SIGNALING BY EGFR | 47 | 7.16e-01 | -0.030700 | 9.14e-01 |
THE PHOTOTRANSDUCTION CASCADE | 21 | 8.08e-01 | 0.030600 | 9.62e-01 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.27e-01 | 0.030600 | 9.66e-01 |
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 21 | 8.09e-01 | 0.030500 | 9.62e-01 |
CELL CELL COMMUNICATION | 105 | 5.91e-01 | -0.030400 | 8.46e-01 |
METABOLISM OF STEROID HORMONES | 20 | 8.14e-01 | -0.030400 | 9.62e-01 |
STABILIZATION OF P53 | 54 | 7.03e-01 | -0.030000 | 9.08e-01 |
UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 8.63e-01 | -0.030000 | 9.76e-01 |
DNA REPLICATION | 122 | 5.69e-01 | 0.029900 | 8.38e-01 |
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 7.83e-01 | 0.029600 | 9.49e-01 |
HIV TRANSCRIPTION INITIATION | 45 | 7.32e-01 | 0.029500 | 9.23e-01 |
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 7.13e-01 | 0.029500 | 9.12e-01 |
MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 8.23e-01 | 0.029000 | 9.65e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 8.47e-01 | 0.028900 | 9.72e-01 |
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 8.69e-01 | -0.028700 | 9.78e-01 |
TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 8.58e-01 | 0.028700 | 9.73e-01 |
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 7.80e-01 | -0.028500 | 9.48e-01 |
GAP JUNCTION ASSEMBLY | 21 | 8.22e-01 | -0.028400 | 9.65e-01 |
POST TRANSLATIONAL PROTEIN MODIFICATION | 1210 | 9.90e-02 | 0.028400 | 4.19e-01 |
RHO GTPASES ACTIVATE FORMINS | 119 | 5.94e-01 | 0.028300 | 8.47e-01 |
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 8.40e-01 | -0.028300 | 9.70e-01 |
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 7.08e-01 | 0.028300 | 9.10e-01 |
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 22 | 8.19e-01 | -0.028100 | 9.64e-01 |
PTEN REGULATION | 134 | 5.76e-01 | 0.028000 | 8.40e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 8.62e-01 | 0.027800 | 9.76e-01 |
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 8.52e-01 | 0.027800 | 9.72e-01 |
CD28 DEPENDENT VAV1 PATHWAY | 11 | 8.74e-01 | -0.027700 | 9.78e-01 |
PLATELET ACTIVATION SIGNALING AND AGGREGATION | 222 | 4.78e-01 | -0.027700 | 7.92e-01 |
PEPTIDE HORMONE METABOLISM | 59 | 7.13e-01 | -0.027700 | 9.12e-01 |
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 6.63e-01 | 0.027500 | 8.86e-01 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 8.81e-01 | 0.027400 | 9.78e-01 |
REGULATION OF KIT SIGNALING | 16 | 8.50e-01 | -0.027300 | 9.72e-01 |
CIRCADIAN CLOCK | 68 | 6.98e-01 | 0.027200 | 9.06e-01 |
PECAM1 INTERACTIONS | 12 | 8.71e-01 | -0.027100 | 9.78e-01 |
KINESINS | 48 | 7.47e-01 | 0.026900 | 9.25e-01 |
MAPK FAMILY SIGNALING CASCADES | 288 | 4.38e-01 | 0.026600 | 7.74e-01 |
PROCESSING AND ACTIVATION OF SUMO | 10 | 8.85e-01 | 0.026400 | 9.78e-01 |
INTERLEUKIN 1 SIGNALING | 95 | 6.58e-01 | -0.026300 | 8.86e-01 |
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 7.91e-01 | 0.026300 | 9.54e-01 |
GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 109 | 6.36e-01 | 0.026200 | 8.76e-01 |
HEDGEHOG OFF STATE | 106 | 6.41e-01 | 0.026200 | 8.76e-01 |
SIGNALING BY LEPTIN | 10 | 8.86e-01 | -0.026100 | 9.78e-01 |
ADHERENS JUNCTIONS INTERACTIONS | 30 | 8.05e-01 | 0.026100 | 9.61e-01 |
ABC TRANSPORTER DISORDERS | 69 | 7.09e-01 | 0.026000 | 9.10e-01 |
SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 6.51e-01 | -0.025800 | 8.80e-01 |
DNA REPLICATION PRE INITIATION | 80 | 6.91e-01 | 0.025700 | 9.03e-01 |
O LINKED GLYCOSYLATION | 83 | 6.89e-01 | 0.025400 | 9.01e-01 |
HCMV EARLY EVENTS | 81 | 6.94e-01 | -0.025300 | 9.04e-01 |
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 7.10e-01 | 0.025200 | 9.10e-01 |
PLASMA LIPOPROTEIN ASSEMBLY | 13 | 8.75e-01 | -0.025200 | 9.78e-01 |
ELASTIC FIBRE FORMATION | 37 | 7.93e-01 | -0.025000 | 9.54e-01 |
SIGNALING BY FGFR1 | 43 | 7.82e-01 | -0.024400 | 9.49e-01 |
LAGGING STRAND SYNTHESIS | 20 | 8.52e-01 | -0.024000 | 9.72e-01 |
PHASE II CONJUGATION OF COMPOUNDS | 62 | 7.44e-01 | -0.024000 | 9.25e-01 |
FERTILIZATION | 10 | 8.96e-01 | -0.023900 | 9.78e-01 |
TRIGLYCERIDE CATABOLISM | 14 | 8.77e-01 | -0.023900 | 9.78e-01 |
INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 4.94e-01 | 0.023700 | 8.01e-01 |
FGFR2 ALTERNATIVE SPLICING | 25 | 8.37e-01 | 0.023700 | 9.70e-01 |
DNA DOUBLE STRAND BREAK REPAIR | 139 | 6.32e-01 | -0.023600 | 8.71e-01 |
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 8.33e-01 | 0.023400 | 9.69e-01 |
ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 8.80e-01 | -0.023300 | 9.78e-01 |
COLLAGEN FORMATION | 77 | 7.24e-01 | 0.023300 | 9.18e-01 |
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 344 | 4.64e-01 | 0.023000 | 7.88e-01 |
GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 8.20e-01 | 0.023000 | 9.64e-01 |
CLASS B 2 SECRETIN FAMILY RECEPTORS | 68 | 7.44e-01 | 0.022900 | 9.25e-01 |
TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 8.16e-01 | -0.022800 | 9.62e-01 |
CYTOPROTECTION BY HMOX1 | 119 | 6.69e-01 | 0.022700 | 8.86e-01 |
SIGNALING BY VEGF | 101 | 6.94e-01 | -0.022700 | 9.04e-01 |
PEROXISOMAL LIPID METABOLISM | 26 | 8.42e-01 | -0.022600 | 9.71e-01 |
PROGRAMMED CELL DEATH | 186 | 6.05e-01 | -0.022000 | 8.55e-01 |
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 7.76e-01 | -0.022000 | 9.46e-01 |
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 8.47e-01 | -0.021900 | 9.72e-01 |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 8.04e-01 | -0.021900 | 9.61e-01 |
INFECTIOUS DISEASE | 734 | 3.17e-01 | -0.021800 | 6.92e-01 |
CHEMOKINE RECEPTORS BIND CHEMOKINES | 13 | 8.92e-01 | 0.021700 | 9.78e-01 |
TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 9.06e-01 | -0.021700 | 9.81e-01 |
UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 28 | 8.43e-01 | -0.021600 | 9.71e-01 |
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 8.81e-01 | 0.021600 | 9.78e-01 |
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 8.58e-01 | 0.021600 | 9.73e-01 |
BETA CATENIN INDEPENDENT WNT SIGNALING | 137 | 6.64e-01 | 0.021500 | 8.86e-01 |
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 8.94e-01 | -0.021400 | 9.78e-01 |
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 8.37e-01 | 0.021400 | 9.70e-01 |
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 8.64e-01 | -0.021100 | 9.76e-01 |
ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 8.96e-01 | 0.020800 | 9.78e-01 |
SIGNALING BY FGFR2 | 62 | 7.78e-01 | 0.020700 | 9.47e-01 |
PYRUVATE METABOLISM | 27 | 8.54e-01 | -0.020400 | 9.72e-01 |
G PROTEIN ACTIVATION | 21 | 8.73e-01 | 0.020200 | 9.78e-01 |
CELL CYCLE MITOTIC | 477 | 4.58e-01 | 0.019900 | 7.88e-01 |
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 3.98e-01 | -0.019800 | 7.51e-01 |
SIGNALING BY FGFR3 | 35 | 8.40e-01 | -0.019700 | 9.70e-01 |
PLASMA LIPOPROTEIN REMODELING | 16 | 8.91e-01 | 0.019700 | 9.78e-01 |
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 7.45e-01 | -0.019600 | 9.25e-01 |
SEMAPHORIN INTERACTIONS | 64 | 7.87e-01 | -0.019500 | 9.53e-01 |
G1 S SPECIFIC TRANSCRIPTION | 26 | 8.64e-01 | -0.019400 | 9.76e-01 |
FCERI MEDIATED NF KB ACTIVATION | 76 | 7.71e-01 | -0.019300 | 9.42e-01 |
MITOTIC SPINDLE CHECKPOINT | 98 | 7.42e-01 | 0.019300 | 9.25e-01 |
MAPK6 MAPK4 SIGNALING | 83 | 7.68e-01 | -0.018700 | 9.40e-01 |
TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.53e-01 | 0.018700 | 9.72e-01 |
METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 8.54e-01 | -0.018600 | 9.72e-01 |
ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 9.05e-01 | 0.018400 | 9.81e-01 |
CHROMATIN MODIFYING ENZYMES | 219 | 6.45e-01 | 0.018100 | 8.77e-01 |
NUCLEOBASE BIOSYNTHESIS | 15 | 9.04e-01 | -0.018000 | 9.81e-01 |
RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 8.85e-01 | -0.017800 | 9.78e-01 |
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 9.23e-01 | -0.017700 | 9.87e-01 |
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 8.65e-01 | -0.017600 | 9.76e-01 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 61 | 8.12e-01 | 0.017600 | 9.62e-01 |
CELL CYCLE | 595 | 4.68e-01 | 0.017500 | 7.88e-01 |
TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 7.74e-01 | -0.017400 | 9.44e-01 |
CELLULAR RESPONSE TO HYPOXIA | 71 | 8.00e-01 | -0.017400 | 9.59e-01 |
HEMOSTASIS | 474 | 5.19e-01 | -0.017400 | 8.17e-01 |
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 8.94e-01 | -0.017300 | 9.78e-01 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 9.26e-01 | 0.016900 | 9.87e-01 |
PYROPTOSIS | 21 | 8.94e-01 | -0.016700 | 9.78e-01 |
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 8.90e-01 | -0.016600 | 9.78e-01 |
UNFOLDED PROTEIN RESPONSE UPR | 85 | 7.92e-01 | -0.016600 | 9.54e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 9.10e-01 | -0.016400 | 9.81e-01 |
SUMOYLATION | 163 | 7.19e-01 | -0.016300 | 9.15e-01 |
SEPARATION OF SISTER CHROMATIDS | 167 | 7.19e-01 | 0.016100 | 9.15e-01 |
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 9.15e-01 | 0.016000 | 9.84e-01 |
MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 8.95e-01 | 0.015800 | 9.78e-01 |
PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 8.33e-01 | 0.015700 | 9.69e-01 |
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 9.32e-01 | 0.015500 | 9.87e-01 |
UCH PROTEINASES | 89 | 8.02e-01 | -0.015400 | 9.60e-01 |
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 8.14e-01 | 0.015400 | 9.62e-01 |
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 8.94e-01 | 0.015100 | 9.78e-01 |
RAB GERANYLGERANYLATION | 58 | 8.44e-01 | 0.014900 | 9.71e-01 |
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 43 | 8.66e-01 | -0.014900 | 9.76e-01 |
DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.91e-01 | -0.014700 | 9.78e-01 |
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 9.27e-01 | -0.014600 | 9.87e-01 |
EPHRIN SIGNALING | 19 | 9.12e-01 | 0.014600 | 9.82e-01 |
NEGATIVE REGULATION OF MET ACTIVITY | 21 | 9.08e-01 | -0.014600 | 9.81e-01 |
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 58 | 8.49e-01 | 0.014500 | 9.72e-01 |
FLT3 SIGNALING | 36 | 8.81e-01 | 0.014400 | 9.78e-01 |
EPHA MEDIATED GROWTH CONE COLLAPSE | 27 | 8.97e-01 | -0.014400 | 9.78e-01 |
POTENTIAL THERAPEUTICS FOR SARS | 77 | 8.30e-01 | -0.014200 | 9.69e-01 |
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 9.34e-01 | -0.013900 | 9.87e-01 |
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 9.35e-01 | 0.013700 | 9.87e-01 |
ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 8.53e-01 | 0.013600 | 9.72e-01 |
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 8.74e-01 | -0.013500 | 9.78e-01 |
METABOLISM OF LIPIDS | 611 | 5.72e-01 | -0.013400 | 8.38e-01 |
MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 9.01e-01 | -0.013300 | 9.81e-01 |
ORC1 REMOVAL FROM CHROMATIN | 67 | 8.54e-01 | 0.013000 | 9.72e-01 |
SIGNALING BY INSULIN RECEPTOR | 61 | 8.63e-01 | 0.012800 | 9.76e-01 |
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 119 | 8.13e-01 | 0.012600 | 9.62e-01 |
METABOLISM OF VITAMINS AND COFACTORS | 153 | 7.89e-01 | 0.012600 | 9.53e-01 |
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 9.18e-01 | -0.012400 | 9.86e-01 |
PEPTIDE LIGAND BINDING RECEPTORS | 105 | 8.26e-01 | -0.012400 | 9.66e-01 |
TRANSCRIPTIONAL REGULATION BY RUNX2 | 108 | 8.27e-01 | -0.012200 | 9.66e-01 |
SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 9.37e-01 | 0.011800 | 9.87e-01 |
RHOU GTPASE CYCLE | 33 | 9.08e-01 | 0.011600 | 9.81e-01 |
SIGNALING BY NODAL | 15 | 9.39e-01 | -0.011500 | 9.87e-01 |
SIGNALING BY NOTCH4 | 83 | 8.57e-01 | 0.011400 | 9.73e-01 |
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 8.88e-01 | 0.011400 | 9.78e-01 |
MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 8.16e-01 | -0.011300 | 9.62e-01 |
REGULATION OF TNFR1 SIGNALING | 34 | 9.10e-01 | 0.011200 | 9.81e-01 |
METAL ION SLC TRANSPORTERS | 24 | 9.25e-01 | -0.011200 | 9.87e-01 |
RHO GTPASE EFFECTORS | 249 | 7.62e-01 | 0.011200 | 9.37e-01 |
SIGNALING BY FGFR2 IIIA TM | 19 | 9.33e-01 | 0.011200 | 9.87e-01 |
CLASS A 1 RHODOPSIN LIKE RECEPTORS | 180 | 7.97e-01 | -0.011100 | 9.58e-01 |
IRE1ALPHA ACTIVATES CHAPERONES | 49 | 8.94e-01 | 0.011000 | 9.78e-01 |
FOXO MEDIATED TRANSCRIPTION | 58 | 8.87e-01 | -0.010700 | 9.78e-01 |
GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 9.52e-01 | -0.010400 | 9.87e-01 |
SIGNALING BY HEDGEHOG | 141 | 8.32e-01 | -0.010300 | 9.69e-01 |
ACTIVATION OF SMO | 16 | 9.44e-01 | -0.010200 | 9.87e-01 |
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 88 | 8.69e-01 | -0.010200 | 9.78e-01 |
SLC MEDIATED TRANSMEMBRANE TRANSPORT | 180 | 8.15e-01 | 0.010100 | 9.62e-01 |
ECM PROTEOGLYCANS | 63 | 8.90e-01 | 0.010100 | 9.78e-01 |
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 68 | 8.86e-01 | 0.010100 | 9.78e-01 |
MISMATCH REPAIR | 15 | 9.47e-01 | 0.009830 | 9.87e-01 |
DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 9.01e-01 | -0.009500 | 9.81e-01 |
PROTEIN LOCALIZATION | 157 | 8.38e-01 | 0.009440 | 9.70e-01 |
RHOV GTPASE CYCLE | 32 | 9.28e-01 | -0.009280 | 9.87e-01 |
CHOLESTEROL BIOSYNTHESIS | 24 | 9.39e-01 | 0.009100 | 9.87e-01 |
ADAPTIVE IMMUNE SYSTEM | 600 | 7.10e-01 | 0.008940 | 9.10e-01 |
RHO GTPASES ACTIVATE CIT | 18 | 9.48e-01 | 0.008830 | 9.87e-01 |
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 9.07e-01 | -0.008810 | 9.81e-01 |
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 9.48e-01 | -0.008700 | 9.87e-01 |
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 64 | 9.06e-01 | -0.008550 | 9.81e-01 |
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 9.22e-01 | -0.008530 | 9.87e-01 |
MICRORNA MIRNA BIOGENESIS | 24 | 9.44e-01 | -0.008320 | 9.87e-01 |
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 117 | 8.79e-01 | -0.008170 | 9.78e-01 |
ENDOGENOUS STEROLS | 21 | 9.49e-01 | -0.008110 | 9.87e-01 |
COLLAGEN DEGRADATION | 50 | 9.24e-01 | 0.007800 | 9.87e-01 |
TNF SIGNALING | 43 | 9.32e-01 | 0.007550 | 9.87e-01 |
GPCR LIGAND BINDING | 260 | 8.35e-01 | 0.007520 | 9.70e-01 |
NGF STIMULATED TRANSCRIPTION | 37 | 9.43e-01 | -0.006840 | 9.87e-01 |
ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 30 | 9.49e-01 | -0.006800 | 9.87e-01 |
P75NTR REGULATES AXONOGENESIS | 10 | 9.71e-01 | 0.006710 | 9.92e-01 |
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 9.69e-01 | -0.006290 | 9.92e-01 |
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 9.47e-01 | -0.006260 | 9.87e-01 |
SIGNALING BY PDGF | 53 | 9.38e-01 | -0.006220 | 9.87e-01 |
RHO GTPASES ACTIVATE ROCKS | 19 | 9.64e-01 | -0.005940 | 9.92e-01 |
REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 9.34e-01 | -0.005880 | 9.87e-01 |
G PROTEIN BETA GAMMA SIGNALLING | 30 | 9.56e-01 | 0.005800 | 9.90e-01 |
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 9.51e-01 | 0.005790 | 9.87e-01 |
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 9.69e-01 | -0.005770 | 9.92e-01 |
TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 9.34e-01 | 0.005690 | 9.87e-01 |
MET ACTIVATES PTK2 SIGNALING | 29 | 9.58e-01 | -0.005630 | 9.91e-01 |
MITOTIC PROPHASE | 95 | 9.26e-01 | -0.005550 | 9.87e-01 |
CD28 CO STIMULATION | 30 | 9.59e-01 | 0.005450 | 9.91e-01 |
RRNA PROCESSING | 195 | 8.96e-01 | -0.005420 | 9.78e-01 |
CELLULAR RESPONSE TO CHEMICAL STRESS | 149 | 9.10e-01 | -0.005350 | 9.81e-01 |
INTERLEUKIN 15 SIGNALING | 13 | 9.74e-01 | -0.005260 | 9.92e-01 |
EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 9.27e-01 | -0.005230 | 9.87e-01 |
PROCESSING OF SMDT1 | 16 | 9.72e-01 | -0.005040 | 9.92e-01 |
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 9.51e-01 | 0.004870 | 9.87e-01 |
SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 9.68e-01 | -0.004530 | 9.92e-01 |
REGULATION OF RAS BY GAPS | 66 | 9.51e-01 | 0.004420 | 9.87e-01 |
HCMV LATE EVENTS | 66 | 9.51e-01 | -0.004390 | 9.87e-01 |
SIGNALING BY NOTCH2 | 33 | 9.66e-01 | 0.004320 | 9.92e-01 |
MATURATION OF NUCLEOPROTEIN | 10 | 9.81e-01 | -0.004280 | 9.92e-01 |
CDC42 GTPASE CYCLE | 153 | 9.31e-01 | 0.004080 | 9.87e-01 |
S PHASE | 154 | 9.32e-01 | 0.003990 | 9.87e-01 |
BIOLOGICAL OXIDATIONS | 125 | 9.41e-01 | 0.003840 | 9.87e-01 |
TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 9.82e-01 | -0.003800 | 9.92e-01 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 9.76e-01 | 0.003690 | 9.92e-01 |
SIGNALING BY NOTCH3 | 48 | 9.65e-01 | 0.003620 | 9.92e-01 |
REGULATION OF BACH1 ACTIVITY | 11 | 9.84e-01 | 0.003570 | 9.92e-01 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 9.78e-01 | -0.003440 | 9.92e-01 |
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 9.64e-01 | -0.003270 | 9.92e-01 |
SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 9.82e-01 | -0.003240 | 9.92e-01 |
LEISHMANIA INFECTION | 197 | 9.38e-01 | -0.003210 | 9.87e-01 |
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 9.63e-01 | -0.002950 | 9.92e-01 |
RNA POLYMERASE II TRANSCRIPTION | 1088 | 8.71e-01 | -0.002950 | 9.78e-01 |
G ALPHA Q SIGNALLING EVENTS | 154 | 9.50e-01 | 0.002940 | 9.87e-01 |
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 22 | 9.81e-01 | -0.002920 | 9.92e-01 |
SIGNALING BY RECEPTOR TYROSINE KINASES | 458 | 9.17e-01 | 0.002850 | 9.86e-01 |
SIGNALING BY FGFR | 72 | 9.69e-01 | 0.002680 | 9.92e-01 |
RAC3 GTPASE CYCLE | 88 | 9.66e-01 | 0.002620 | 9.92e-01 |
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 9.84e-01 | -0.002580 | 9.92e-01 |
TELOMERE EXTENSION BY TELOMERASE | 22 | 9.84e-01 | 0.002470 | 9.92e-01 |
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 10 | 9.90e-01 | 0.002220 | 9.93e-01 |
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 9.73e-01 | 0.002200 | 9.92e-01 |
EXTENSION OF TELOMERES | 49 | 9.79e-01 | -0.002130 | 9.92e-01 |
MAP2K AND MAPK ACTIVATION | 36 | 9.83e-01 | 0.002110 | 9.92e-01 |
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 9.91e-01 | 0.001680 | 9.93e-01 |
GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 9.83e-01 | 0.001630 | 9.92e-01 |
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 9.86e-01 | 0.001620 | 9.92e-01 |
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 9.85e-01 | -0.001490 | 9.92e-01 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 9.94e-01 | -0.001460 | 9.94e-01 |
RHOB GTPASE CYCLE | 67 | 9.84e-01 | 0.001420 | 9.92e-01 |
SYNTHESIS OF PA | 29 | 9.90e-01 | 0.001360 | 9.93e-01 |
RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 9.84e-01 | 0.001280 | 9.92e-01 |
RNA POLYMERASE I TRANSCRIPTION | 68 | 9.86e-01 | -0.001240 | 9.92e-01 |
DEGRADATION OF AXIN | 53 | 9.88e-01 | 0.001180 | 9.92e-01 |
RESOLUTION OF SISTER CHROMATID COHESION | 103 | 9.87e-01 | -0.000917 | 9.92e-01 |
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 10 | 9.98e-01 | -0.000388 | 9.98e-01 |
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
784 | |
---|---|
set | REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO |
setSize | 10 |
pANOVA | 0.00196 |
s.dist | 0.566 |
p.adjustANOVA | 0.0528 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nell2 | 8334 |
Slit2 | 7715 |
Slit3 | 7397 |
Robo2 | 6798 |
Ntn1 | 4776 |
Src | 4689 |
Robo3 | 4576 |
Slit1 | 4244 |
Robo1 | -190 |
Dcc | -470 |
GeneID | Gene Rank |
---|---|
Nell2 | 8334 |
Slit2 | 7715 |
Slit3 | 7397 |
Robo2 | 6798 |
Ntn1 | 4776 |
Src | 4689 |
Robo3 | 4576 |
Slit1 | 4244 |
Robo1 | -190 |
Dcc | -470 |
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
1095 | |
---|---|
set | TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS |
setSize | 17 |
pANOVA | 7.94e-05 |
s.dist | 0.553 |
p.adjustANOVA | 0.00924 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Prkcg | 7934 |
Ap2a1 | 7394 |
Nsf | 7135 |
Ap2b1 | 7080 |
Prkcb | 6741 |
Ap2a2 | 6358 |
Gria3 | 6301 |
Pick1 | 5747 |
Ap2m1 | 5729 |
Gria1 | 5278 |
Grip1 | 4534 |
Gria2 | 3969 |
Ap2s1 | 2536 |
Tspan7 | 1433 |
Gria4 | 120 |
Grip2 | -6880 |
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Prkcg | 7934 |
Ap2a1 | 7394 |
Nsf | 7135 |
Ap2b1 | 7080 |
Prkcb | 6741 |
Ap2a2 | 6358 |
Gria3 | 6301 |
Pick1 | 5747 |
Ap2m1 | 5729 |
Gria1 | 5278 |
Grip1 | 4534 |
Gria2 | 3969 |
Ap2s1 | 2536 |
Tspan7 | 1433 |
Gria4 | 120 |
Grip2 | -6880 |
SYNAPTIC ADHESION LIKE MOLECULES
1022 | |
---|---|
set | SYNAPTIC ADHESION LIKE MOLECULES |
setSize | 21 |
pANOVA | 3.89e-05 |
s.dist | 0.519 |
p.adjustANOVA | 0.00503 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Lrfn4 | 7994 |
Ptprs | 7795 |
Grin1 | 7629 |
Dlg3 | 7480 |
Grin2c | 7110 |
Dlg4 | 6940 |
Gria3 | 6301 |
Lrfn2 | 6283 |
Grin2b | 6241 |
Lrfn1 | 5481 |
Gria1 | 5278 |
Grin2a | 4615 |
Flot1 | 3791 |
Lrfn3 | 3175 |
Ptprf | 2822 |
Flot2 | 2657 |
Rtn3 | 2122 |
Ptprd | 278 |
Gria4 | 120 |
Dlg1 | 61 |
GeneID | Gene Rank |
---|---|
Lrfn4 | 7994 |
Ptprs | 7795 |
Grin1 | 7629 |
Dlg3 | 7480 |
Grin2c | 7110 |
Dlg4 | 6940 |
Gria3 | 6301 |
Lrfn2 | 6283 |
Grin2b | 6241 |
Lrfn1 | 5481 |
Gria1 | 5278 |
Grin2a | 4615 |
Flot1 | 3791 |
Lrfn3 | 3175 |
Ptprf | 2822 |
Flot2 | 2657 |
Rtn3 | 2122 |
Ptprd | 278 |
Gria4 | 120 |
Dlg1 | 61 |
Grin2d | -2102 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION
167 | |
---|---|
set | COMMON PATHWAY OF FIBRIN CLOT FORMATION |
setSize | 11 |
pANOVA | 0.00323 |
s.dist | -0.513 |
p.adjustANOVA | 0.0767 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpine2 | -7671 |
Procr | -7567 |
Pros1 | -6994 |
Serpind1 | -6322 |
F8 | -6292 |
F2r | -5645 |
F13a1 | -3810 |
Serpinc1 | -3407 |
Prtn3 | -1921 |
F5 | 495 |
Thbd | 974 |
GeneID | Gene Rank |
---|---|
Serpine2 | -7671 |
Procr | -7567 |
Pros1 | -6994 |
Serpind1 | -6322 |
F8 | -6292 |
F2r | -5645 |
F13a1 | -3810 |
Serpinc1 | -3407 |
Prtn3 | -1921 |
F5 | 495 |
Thbd | 974 |
WNT5A DEPENDENT INTERNALIZATION OF FZD4
1161 | |
---|---|
set | WNT5A DEPENDENT INTERNALIZATION OF FZD4 |
setSize | 15 |
pANOVA | 0.000709 |
s.dist | 0.505 |
p.adjustANOVA | 0.0344 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Prkcg | 7934 |
Ap2a1 | 7394 |
Ap2b1 | 7080 |
Prkcb | 6741 |
Dvl2 | 6555 |
Ap2a2 | 6358 |
Ap2m1 | 5729 |
Arrb2 | 4011 |
Clta | 2910 |
Ap2s1 | 2536 |
Cltb | 1571 |
Cltc | 1187 |
Wnt5a | -1070 |
Fzd4 | -2968 |
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Prkcg | 7934 |
Ap2a1 | 7394 |
Ap2b1 | 7080 |
Prkcb | 6741 |
Dvl2 | 6555 |
Ap2a2 | 6358 |
Ap2m1 | 5729 |
Arrb2 | 4011 |
Clta | 2910 |
Ap2s1 | 2536 |
Cltb | 1571 |
Cltc | 1187 |
Wnt5a | -1070 |
Fzd4 | -2968 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
80 | |
---|---|
set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
setSize | 10 |
pANOVA | 0.00592 |
s.dist | -0.503 |
p.adjustANOVA | 0.123 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa5 | -8508 |
Xbp1 | -8476 |
Hsp90b1 | -8419 |
Nfya | -8351 |
Calr | -8276 |
Ddit3 | -7358 |
Atf4 | -3829 |
Nfyc | -47 |
Nfyb | 4588 |
Atf6 | 5760 |
GeneID | Gene Rank |
---|---|
Hspa5 | -8508 |
Xbp1 | -8476 |
Hsp90b1 | -8419 |
Nfya | -8351 |
Calr | -8276 |
Ddit3 | -7358 |
Atf4 | -3829 |
Nfyc | -47 |
Nfyb | 4588 |
Atf6 | 5760 |
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
109 | |
---|---|
set | CAMK IV MEDIATED PHOSPHORYLATION OF CREB |
setSize | 10 |
pANOVA | 0.00673 |
s.dist | 0.495 |
p.adjustANOVA | 0.124 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Camkk2 | 8297 |
Camkk1 | 8221 |
Camk2b | 8027 |
Kpna2 | 7487 |
Camk2a | 7008 |
Camk4 | 4797 |
Camk2d | 4345 |
Camk2g | 2899 |
Calm1 | -2523 |
Creb1 | -6695 |
GeneID | Gene Rank |
---|---|
Camkk2 | 8297 |
Camkk1 | 8221 |
Camk2b | 8027 |
Kpna2 | 7487 |
Camk2a | 7008 |
Camk4 | 4797 |
Camk2d | 4345 |
Camk2g | 2899 |
Calm1 | -2523 |
Creb1 | -6695 |
CGMP EFFECTS
141 | |
---|---|
set | CGMP EFFECTS |
setSize | 15 |
pANOVA | 0.00094 |
s.dist | 0.493 |
p.adjustANOVA | 0.0365 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pde1a | 8218 |
Pde11a | 7583 |
Kcnmb2 | 7467 |
Pde2a | 7424 |
Pde9a | 7242 |
Kcnmb4 | 6993 |
Kcnma1 | 6073 |
Itpr1 | 5676 |
Irag1 | 5277 |
Pde1b | 5215 |
Kcnmb1 | 4711 |
Pde10a | 861 |
Pde5a | -388 |
Prkg1 | -2456 |
Prkg2 | -7323 |
GeneID | Gene Rank |
---|---|
Pde1a | 8218 |
Pde11a | 7583 |
Kcnmb2 | 7467 |
Pde2a | 7424 |
Pde9a | 7242 |
Kcnmb4 | 6993 |
Kcnma1 | 6073 |
Itpr1 | 5676 |
Irag1 | 5277 |
Pde1b | 5215 |
Kcnmb1 | 4711 |
Pde10a | 861 |
Pde5a | -388 |
Prkg1 | -2456 |
Prkg2 | -7323 |
DNA METHYLATION
251 | |
---|---|
set | DNA METHYLATION |
setSize | 20 |
pANOVA | 0.000442 |
s.dist | -0.454 |
p.adjustANOVA | 0.0245 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
Uhrf1 | -7604 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Dnmt3a | -4563 |
H3c15 | -4019 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
H3f3b | -414 |
H4c14 | 138 |
H2ax | 4083 |
Dnmt1 | 5612 |
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
Uhrf1 | -7604 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Dnmt3a | -4563 |
H3c15 | -4019 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
H3f3b | -414 |
H4c14 | 138 |
H2ax | 4083 |
Dnmt1 | 5612 |
LGI ADAM INTERACTIONS
511 | |
---|---|
set | LGI ADAM INTERACTIONS |
setSize | 14 |
pANOVA | 0.00348 |
s.dist | 0.451 |
p.adjustANOVA | 0.081 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Cacng3 | 7889 |
Adam11 | 7834 |
Cacng8 | 7549 |
Dlg4 | 6940 |
Stx1b | 5641 |
Lgi3 | 5514 |
Adam22 | 3626 |
Adam23 | 2458 |
Lgi1 | 1211 |
Lgi4 | 814 |
Lgi2 | -245 |
Cacng4 | -372 |
Cacng2 | -3424 |
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Cacng3 | 7889 |
Adam11 | 7834 |
Cacng8 | 7549 |
Dlg4 | 6940 |
Stx1b | 5641 |
Lgi3 | 5514 |
Adam22 | 3626 |
Adam23 | 2458 |
Lgi1 | 1211 |
Lgi4 | 814 |
Lgi2 | -245 |
Cacng4 | -372 |
Cacng2 | -3424 |
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
1117 | |
---|---|
set | TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX |
setSize | 12 |
pANOVA | 0.00692 |
s.dist | 0.45 |
p.adjustANOVA | 0.124 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Chmp6 | 7060 |
Chmp3 | 6443 |
Pik3r4 | 6435 |
Becn1 | 5034 |
Pik3c3 | 4940 |
Chmp4b | 4061 |
Chmp7 | 3408 |
Chmp2b | 3035 |
Map1lc3b | 2678 |
Chmp2a | 2450 |
Chmp4c | 1140 |
Uvrag | -1008 |
GeneID | Gene Rank |
---|---|
Chmp6 | 7060 |
Chmp3 | 6443 |
Pik3r4 | 6435 |
Becn1 | 5034 |
Pik3c3 | 4940 |
Chmp4b | 4061 |
Chmp7 | 3408 |
Chmp2b | 3035 |
Map1lc3b | 2678 |
Chmp2a | 2450 |
Chmp4c | 1140 |
Uvrag | -1008 |
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
913 | |
---|---|
set | SEROTONIN NEUROTRANSMITTER RELEASE CYCLE |
setSize | 18 |
pANOVA | 0.00102 |
s.dist | 0.447 |
p.adjustANOVA | 0.0379 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Syn1 | 7354 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Syn2 | 5671 |
Syn3 | 4255 |
Rab3a | 4251 |
Vamp2 | 4007 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cplx1 | 512 |
Ppfia1 | -2775 |
Slc18a2 | -8364 |
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Syn1 | 7354 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Syn2 | 5671 |
Syn3 | 4255 |
Rab3a | 4251 |
Vamp2 | 4007 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cplx1 | 512 |
Ppfia1 | -2775 |
Slc18a2 | -8364 |
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
1093 | |
---|---|
set | TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR |
setSize | 11 |
pANOVA | 0.0112 |
s.dist | -0.442 |
p.adjustANOVA | 0.143 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hsp90b1 | -8419 |
Tlr3 | -7950 |
Ctss | -7927 |
Lgmn | -5222 |
Ctsl | -4944 |
Ctsk | -4723 |
Unc93b1 | -3682 |
Tlr7 | -3257 |
Tlr9 | 101 |
Ctsb | 727 |
Cnpy3 | 3782 |
GeneID | Gene Rank |
---|---|
Hsp90b1 | -8419 |
Tlr3 | -7950 |
Ctss | -7927 |
Lgmn | -5222 |
Ctsl | -4944 |
Ctsk | -4723 |
Unc93b1 | -3682 |
Tlr7 | -3257 |
Tlr9 | 101 |
Ctsb | 727 |
Cnpy3 | 3782 |
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS
234 | |
---|---|
set | DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS |
setSize | 18 |
pANOVA | 0.00126 |
s.dist | 0.439 |
p.adjustANOVA | 0.0408 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Srd5a3 | 7833 |
Glb1 | 7481 |
Mpi | 7156 |
Dolk | 6220 |
Dpm3 | 6197 |
Dhdds | 6188 |
Gne | 6149 |
Galt | 5683 |
Gale | 4936 |
Dpm1 | 4736 |
Ctsa | 3765 |
Dpm2 | 3381 |
Neu1 | 2229 |
Pmm2 | 2162 |
Galk1 | 1265 |
Pgm1 | -1727 |
Gfpt1 | -2249 |
Nus1 | -4630 |
GeneID | Gene Rank |
---|---|
Srd5a3 | 7833 |
Glb1 | 7481 |
Mpi | 7156 |
Dolk | 6220 |
Dpm3 | 6197 |
Dhdds | 6188 |
Gne | 6149 |
Galt | 5683 |
Gale | 4936 |
Dpm1 | 4736 |
Ctsa | 3765 |
Dpm2 | 3381 |
Neu1 | 2229 |
Pmm2 | 2162 |
Galk1 | 1265 |
Pgm1 | -1727 |
Gfpt1 | -2249 |
Nus1 | -4630 |
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
653 | |
---|---|
set | NUCLEOTIDE LIKE PURINERGIC RECEPTORS |
setSize | 12 |
pANOVA | 0.00852 |
s.dist | -0.439 |
p.adjustANOVA | 0.13 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Adora3 | -8301 |
P2ry13 | -8282 |
Adora2b | -7728 |
Gpr17 | -7614 |
P2ry12 | -7476 |
P2ry14 | -5282 |
Lpar4 | -5063 |
P2ry6 | -3039 |
Lpar6 | -1656 |
P2ry1 | 464 |
Adora2a | 591 |
Adora1 | 8419 |
GeneID | Gene Rank |
---|---|
Adora3 | -8301 |
P2ry13 | -8282 |
Adora2b | -7728 |
Gpr17 | -7614 |
P2ry12 | -7476 |
P2ry14 | -5282 |
Lpar4 | -5063 |
P2ry6 | -3039 |
Lpar6 | -1656 |
P2ry1 | 464 |
Adora2a | 591 |
Adora1 | 8419 |
MUCOPOLYSACCHARIDOSES
583 | |
---|---|
set | MUCOPOLYSACCHARIDOSES |
setSize | 11 |
pANOVA | 0.012 |
s.dist | 0.437 |
p.adjustANOVA | 0.148 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Naglu | 8479 |
Glb1 | 7481 |
Galns | 5932 |
Hgsnat | 5889 |
Sgsh | 5045 |
Arsb | 4866 |
Hyal1 | 4403 |
Gns | 1421 |
Gusb | 460 |
Ids | -1372 |
Idua | -1926 |
GeneID | Gene Rank |
---|---|
Naglu | 8479 |
Glb1 | 7481 |
Galns | 5932 |
Hgsnat | 5889 |
Sgsh | 5045 |
Arsb | 4866 |
Hyal1 | 4403 |
Gns | 1421 |
Gusb | 460 |
Ids | -1372 |
Idua | -1926 |
TRAFFICKING OF AMPA RECEPTORS
1094 | |
---|---|
set | TRAFFICKING OF AMPA RECEPTORS |
setSize | 31 |
pANOVA | 2.84e-05 |
s.dist | 0.434 |
p.adjustANOVA | 0.00456 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Camk2b | 8027 |
Prkcg | 7934 |
Cacng3 | 7889 |
Cacng8 | 7549 |
Ap2a1 | 7394 |
Nsf | 7135 |
Ap2b1 | 7080 |
Camk2a | 7008 |
Dlg4 | 6940 |
Prkcb | 6741 |
Ap2a2 | 6358 |
Gria3 | 6301 |
Akap5 | 6204 |
Pick1 | 5747 |
Ap2m1 | 5729 |
Gria1 | 5278 |
Grip1 | 4534 |
Camk2d | 4345 |
Gria2 | 3969 |
GeneID | Gene Rank |
---|---|
Prkca | 8091 |
Camk2b | 8027 |
Prkcg | 7934 |
Cacng3 | 7889 |
Cacng8 | 7549 |
Ap2a1 | 7394 |
Nsf | 7135 |
Ap2b1 | 7080 |
Camk2a | 7008 |
Dlg4 | 6940 |
Prkcb | 6741 |
Ap2a2 | 6358 |
Gria3 | 6301 |
Akap5 | 6204 |
Pick1 | 5747 |
Ap2m1 | 5729 |
Gria1 | 5278 |
Grip1 | 4534 |
Camk2d | 4345 |
Gria2 | 3969 |
Camk2g | 2899 |
Ap2s1 | 2536 |
Epb41l1 | 1917 |
Tspan7 | 1433 |
Gria4 | 120 |
Dlg1 | 61 |
Cacng4 | -372 |
Cacng2 | -3424 |
Grip2 | -6880 |
Myo6 | -7334 |
Mdm2 | -7509 |
SHC MEDIATED CASCADE FGFR4
917 | |
---|---|
set | SHC MEDIATED CASCADE FGFR4 |
setSize | 11 |
pANOVA | 0.0152 |
s.dist | -0.423 |
p.adjustANOVA | 0.175 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgf9 | -8111 |
Nras | -8042 |
Fgf2 | -8002 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Kras | -4796 |
Sos1 | -4081 |
Shc1 | -3374 |
Hras | -19 |
Grb2 | 4493 |
Fgf16 | 7270 |
GeneID | Gene Rank |
---|---|
Fgf9 | -8111 |
Nras | -8042 |
Fgf2 | -8002 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Kras | -4796 |
Sos1 | -4081 |
Shc1 | -3374 |
Hras | -19 |
Grb2 | 4493 |
Fgf16 | 7270 |
SIGNALING BY HIPPO
953 | |
---|---|
set | SIGNALING BY HIPPO |
setSize | 20 |
pANOVA | 0.00124 |
s.dist | -0.417 |
p.adjustANOVA | 0.0408 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tjp2 | -8083 |
Amotl2 | -7597 |
Sav1 | -7390 |
Amotl1 | -7259 |
Tjp1 | -7253 |
Stk3 | -6856 |
Mob1a | -6776 |
Casp3 | -6671 |
Wwtr1 | -5903 |
Stk4 | -5711 |
Lats1 | -5682 |
Mob1b | -5515 |
Lats2 | -4702 |
Amot | -4025 |
Ywhae | -970 |
Yap1 | 1104 |
Wwc1 | 1524 |
Ywhab | 1545 |
Dvl2 | 6555 |
Nphp4 | 8375 |
GeneID | Gene Rank |
---|---|
Tjp2 | -8083 |
Amotl2 | -7597 |
Sav1 | -7390 |
Amotl1 | -7259 |
Tjp1 | -7253 |
Stk3 | -6856 |
Mob1a | -6776 |
Casp3 | -6671 |
Wwtr1 | -5903 |
Stk4 | -5711 |
Lats1 | -5682 |
Mob1b | -5515 |
Lats2 | -4702 |
Amot | -4025 |
Ywhae | -970 |
Yap1 | 1104 |
Wwc1 | 1524 |
Ywhab | 1545 |
Dvl2 | 6555 |
Nphp4 | 8375 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
483 | |
---|---|
set | INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION |
setSize | 13 |
pANOVA | 0.0101 |
s.dist | -0.412 |
p.adjustANOVA | 0.137 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpine2 | -7671 |
Pros1 | -6994 |
Vwf | -6657 |
Serpind1 | -6322 |
F8 | -6292 |
Prcp | -5390 |
Serping1 | -4239 |
Serpinc1 | -3407 |
Gp5 | -3223 |
Gp1bb | -1929 |
C1qbp | -1897 |
A2m | -141 |
Gp1ba | 8379 |
GeneID | Gene Rank |
---|---|
Serpine2 | -7671 |
Pros1 | -6994 |
Vwf | -6657 |
Serpind1 | -6322 |
F8 | -6292 |
Prcp | -5390 |
Serping1 | -4239 |
Serpinc1 | -3407 |
Gp5 | -3223 |
Gp1bb | -1929 |
C1qbp | -1897 |
A2m | -141 |
Gp1ba | 8379 |
HSF1 ACTIVATION
426 | |
---|---|
set | HSF1 ACTIVATION |
setSize | 27 |
pANOVA | 0.00024 |
s.dist | -0.408 |
p.adjustANOVA | 0.0174 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8522 |
Hspb1 | -8520 |
Fkbp4 | -8515 |
Hsph1 | -8479 |
Hspa1b | -8409 |
Hspa1a | -8371 |
Dnajb1 | -8303 |
Hsp90aa1 | -7811 |
Dedd2 | -7321 |
Rpa1 | -6820 |
Ptges3 | -6554 |
Col4a6 | -5419 |
Hsp90ab1 | -4459 |
Rln1 | -3680 |
Rpa2 | -2399 |
Mrpl18 | -2116 |
Cryba4 | -1416 |
Dnajb6 | -1244 |
Ywhae | -970 |
Eef1a1 | -401 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8522 |
Hspb1 | -8520 |
Fkbp4 | -8515 |
Hsph1 | -8479 |
Hspa1b | -8409 |
Hspa1a | -8371 |
Dnajb1 | -8303 |
Hsp90aa1 | -7811 |
Dedd2 | -7321 |
Rpa1 | -6820 |
Ptges3 | -6554 |
Col4a6 | -5419 |
Hsp90ab1 | -4459 |
Rln1 | -3680 |
Rpa2 | -2399 |
Mrpl18 | -2116 |
Cryba4 | -1416 |
Dnajb6 | -1244 |
Ywhae | -970 |
Eef1a1 | -401 |
Rpa3 | 478 |
Hdac6 | 558 |
Vcp | 799 |
Ubb | 1348 |
Hsf1 | 2256 |
Hsbp1 | 3840 |
Tnfrsf21 | 6286 |
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
1144 | |
---|---|
set | UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION |
setSize | 21 |
pANOVA | 0.00131 |
s.dist | 0.405 |
p.adjustANOVA | 0.0413 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Camk2b | 8027 |
Grin1 | 7629 |
Dlg3 | 7480 |
Grin2c | 7110 |
Camk2a | 7008 |
Dlg4 | 6940 |
Gria3 | 6301 |
Grin2b | 6241 |
Actn2 | 5570 |
Gria1 | 5278 |
Grin2a | 4615 |
Camk2d | 4345 |
Gria2 | 3969 |
Camk2g | 2899 |
Lrrc7 | 2260 |
Gria4 | 120 |
Dlg1 | 61 |
Grin2d | -2102 |
Calm1 | -2523 |
Dlg2 | -3794 |
GeneID | Gene Rank |
---|---|
Camk2b | 8027 |
Grin1 | 7629 |
Dlg3 | 7480 |
Grin2c | 7110 |
Camk2a | 7008 |
Dlg4 | 6940 |
Gria3 | 6301 |
Grin2b | 6241 |
Actn2 | 5570 |
Gria1 | 5278 |
Grin2a | 4615 |
Camk2d | 4345 |
Gria2 | 3969 |
Camk2g | 2899 |
Lrrc7 | 2260 |
Gria4 | 120 |
Dlg1 | 61 |
Grin2d | -2102 |
Calm1 | -2523 |
Dlg2 | -3794 |
Nefl | -5602 |
SIGNALING BY FGFR3 FUSIONS IN CANCER
946 | |
---|---|
set | SIGNALING BY FGFR3 FUSIONS IN CANCER |
setSize | 10 |
pANOVA | 0.0269 |
s.dist | -0.404 |
p.adjustANOVA | 0.232 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gab1 | -8223 |
Nras | -8042 |
Pik3ca | -7797 |
Kras | -4796 |
Frs2 | -4087 |
Sos1 | -4081 |
Fgfr3 | -4029 |
Hras | -19 |
Pik3r1 | 2027 |
Grb2 | 4493 |
GeneID | Gene Rank |
---|---|
Gab1 | -8223 |
Nras | -8042 |
Pik3ca | -7797 |
Kras | -4796 |
Frs2 | -4087 |
Sos1 | -4081 |
Fgfr3 | -4029 |
Hras | -19 |
Pik3r1 | 2027 |
Grb2 | 4493 |
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
729 | |
---|---|
set | PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING |
setSize | 11 |
pANOVA | 0.0213 |
s.dist | 0.401 |
p.adjustANOVA | 0.208 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Cacna1b | 7716 |
Cacna1e | 7333 |
Cacnb3 | 6883 |
Cacnb1 | 6597 |
Cacna1a | 5931 |
Cacna2d3 | 4358 |
Cacnb2 | 1475 |
Cacna2d2 | 1251 |
Cacng4 | -372 |
Cacnb4 | -469 |
Cacng2 | -3424 |
GeneID | Gene Rank |
---|---|
Cacna1b | 7716 |
Cacna1e | 7333 |
Cacnb3 | 6883 |
Cacnb1 | 6597 |
Cacna1a | 5931 |
Cacna2d3 | 4358 |
Cacnb2 | 1475 |
Cacna2d2 | 1251 |
Cacng4 | -372 |
Cacnb4 | -469 |
Cacng2 | -3424 |
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10
618 | |
---|---|
set | NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 |
setSize | 11 |
pANOVA | 0.0218 |
s.dist | -0.399 |
p.adjustANOVA | 0.21 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Ripk1 | -7581 |
Casp8 | -7196 |
Chuk | -6067 |
Rnf135 | -4521 |
Trim25 | -2446 |
Ddx58 | -2254 |
Mavs | -1764 |
Ikbkg | -1408 |
Ikbkb | 397 |
Fadd | 3615 |
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Ripk1 | -7581 |
Casp8 | -7196 |
Chuk | -6067 |
Rnf135 | -4521 |
Trim25 | -2446 |
Ddx58 | -2254 |
Mavs | -1764 |
Ikbkg | -1408 |
Ikbkb | 397 |
Fadd | 3615 |
CONDENSATION OF PROPHASE CHROMOSOMES
170 | |
---|---|
set | CONDENSATION OF PROPHASE CHROMOSOMES |
setSize | 28 |
pANOVA | 0.000297 |
s.dist | -0.395 |
p.adjustANOVA | 0.0182 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
Kmt5a | -6768 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Smc2 | -6023 |
Smc4 | -5878 |
Ncapg2 | -5514 |
Set | -4883 |
H3c15 | -4019 |
Rb1 | -3454 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
Kmt5a | -6768 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Smc2 | -6023 |
Smc4 | -5878 |
Ncapg2 | -5514 |
Set | -4883 |
H3c15 | -4019 |
Rb1 | -3454 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
Mcph1 | -454 |
H3f3b | -414 |
Ncapd3 | -249 |
H4c14 | 138 |
Plk1 | 1976 |
Phf8 | 2818 |
H2ax | 4083 |
Ncaph2 | 4911 |
CROSSLINKING OF COLLAGEN FIBRILS
189 | |
---|---|
set | CROSSLINKING OF COLLAGEN FIBRILS |
setSize | 14 |
pANOVA | 0.0112 |
s.dist | 0.391 |
p.adjustANOVA | 0.143 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pcolce | 7956 |
Col4a2 | 7647 |
Pxdn | 6822 |
Bmp1 | 6796 |
Col1a1 | 6512 |
Tll1 | 6180 |
Col4a1 | 5625 |
Loxl1 | 4862 |
Loxl2 | 4292 |
Col4a5 | 1455 |
Loxl3 | -1273 |
Tll2 | -2579 |
Col1a2 | -2588 |
Col4a6 | -5419 |
GeneID | Gene Rank |
---|---|
Pcolce | 7956 |
Col4a2 | 7647 |
Pxdn | 6822 |
Bmp1 | 6796 |
Col1a1 | 6512 |
Tll1 | 6180 |
Col4a1 | 5625 |
Loxl1 | 4862 |
Loxl2 | 4292 |
Col4a5 | 1455 |
Loxl3 | -1273 |
Tll2 | -2579 |
Col1a2 | -2588 |
Col4a6 | -5419 |
NEUROTOXICITY OF CLOSTRIDIUM TOXINS
614 | |
---|---|
set | NEUROTOXICITY OF CLOSTRIDIUM TOXINS |
setSize | 10 |
pANOVA | 0.0324 |
s.dist | 0.391 |
p.adjustANOVA | 0.248 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Sv2b | 8281 |
Stx1a | 7938 |
Syt1 | 6858 |
Stx1b | 5641 |
Sv2a | 4695 |
Vamp2 | 4007 |
Snap25 | 2764 |
Sv2c | 1325 |
Syt2 | -4028 |
Vamp1 | -4481 |
GeneID | Gene Rank |
---|---|
Sv2b | 8281 |
Stx1a | 7938 |
Syt1 | 6858 |
Stx1b | 5641 |
Sv2a | 4695 |
Vamp2 | 4007 |
Snap25 | 2764 |
Sv2c | 1325 |
Syt2 | -4028 |
Vamp1 | -4481 |
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
116 | |
---|---|
set | CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND |
setSize | 13 |
pANOVA | 0.0152 |
s.dist | -0.389 |
p.adjustANOVA | 0.175 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Tnfsf10 | -8485 |
Cd14 | -8329 |
Ripk1 | -7581 |
Tlr4 | -7369 |
Casp8 | -7196 |
Tnfrsf10b | -5896 |
Ticam2 | -5065 |
Cflar | -2954 |
Traf2 | -2620 |
Tradd | 990 |
Fas | 3329 |
Fadd | 3615 |
Ticam1 | 4321 |
GeneID | Gene Rank |
---|---|
Tnfsf10 | -8485 |
Cd14 | -8329 |
Ripk1 | -7581 |
Tlr4 | -7369 |
Casp8 | -7196 |
Tnfrsf10b | -5896 |
Ticam2 | -5065 |
Cflar | -2954 |
Traf2 | -2620 |
Tradd | 990 |
Fas | 3329 |
Fadd | 3615 |
Ticam1 | 4321 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
81 | |
---|---|
set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONES |
setSize | 12 |
pANOVA | 0.0199 |
s.dist | -0.388 |
p.adjustANOVA | 0.202 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Hspa5 | -8508 |
Xbp1 | -8476 |
Hsp90b1 | -8419 |
Nfya | -8351 |
Calr | -8276 |
Ddit3 | -7358 |
Atf4 | -3829 |
Mbtps2 | -3818 |
Nfyc | -47 |
Nfyb | 4588 |
Atf6 | 5760 |
Mbtps1 | 6915 |
GeneID | Gene Rank |
---|---|
Hspa5 | -8508 |
Xbp1 | -8476 |
Hsp90b1 | -8419 |
Nfya | -8351 |
Calr | -8276 |
Ddit3 | -7358 |
Atf4 | -3829 |
Mbtps2 | -3818 |
Nfyc | -47 |
Nfyb | 4588 |
Atf6 | 5760 |
Mbtps1 | 6915 |
RETROGRADE NEUROTROPHIN SIGNALLING
834 | |
---|---|
set | RETROGRADE NEUROTROPHIN SIGNALLING |
setSize | 14 |
pANOVA | 0.0121 |
s.dist | 0.387 |
p.adjustANOVA | 0.148 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Dnm1 | 7420 |
Ap2a1 | 7394 |
Ap2b1 | 7080 |
Ap2a2 | 6358 |
Sh3gl2 | 6061 |
Ap2m1 | 5729 |
Dnal4 | 3744 |
Clta | 2910 |
Ap2s1 | 2536 |
Ngf | 2217 |
Cltc | 1187 |
Dnm2 | -552 |
Ntrk1 | -1523 |
Dnm3 | -4756 |
GeneID | Gene Rank |
---|---|
Dnm1 | 7420 |
Ap2a1 | 7394 |
Ap2b1 | 7080 |
Ap2a2 | 6358 |
Sh3gl2 | 6061 |
Ap2m1 | 5729 |
Dnal4 | 3744 |
Clta | 2910 |
Ap2s1 | 2536 |
Ngf | 2217 |
Cltc | 1187 |
Dnm2 | -552 |
Ntrk1 | -1523 |
Dnm3 | -4756 |
TRAF6 MEDIATED IRF7 ACTIVATION
1090 | |
---|---|
set | TRAF6 MEDIATED IRF7 ACTIVATION |
setSize | 15 |
pANOVA | 0.0102 |
s.dist | -0.383 |
p.adjustANOVA | 0.137 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Irf7 | -8101 |
Traf6 | -7783 |
Tank | -5965 |
Tbk1 | -5931 |
Rnf135 | -4521 |
Sike1 | -3450 |
Traf2 | -2620 |
Trim25 | -2446 |
Ep300 | -2267 |
Ddx58 | -2254 |
Mavs | -1764 |
Irf3 | -1173 |
Crebbp | 2884 |
Ikbke | 4612 |
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Irf7 | -8101 |
Traf6 | -7783 |
Tank | -5965 |
Tbk1 | -5931 |
Rnf135 | -4521 |
Sike1 | -3450 |
Traf2 | -2620 |
Trim25 | -2446 |
Ep300 | -2267 |
Ddx58 | -2254 |
Mavs | -1764 |
Irf3 | -1173 |
Crebbp | 2884 |
Ikbke | 4612 |
ATTENUATION PHASE
82 | |
---|---|
set | ATTENUATION PHASE |
setSize | 25 |
pANOVA | 0.000934 |
s.dist | -0.382 |
p.adjustANOVA | 0.0365 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Serpinh1 | -8522 |
Hspb1 | -8520 |
Fkbp4 | -8515 |
Hsph1 | -8479 |
Hspa1b | -8409 |
Hspa1a | -8371 |
Dnajb1 | -8303 |
Hsp90aa1 | -7811 |
Hspa8 | -7724 |
Dedd2 | -7321 |
Ptges3 | -6554 |
Col4a6 | -5419 |
Hsp90ab1 | -4459 |
Rln1 | -3680 |
Ep300 | -2267 |
Mrpl18 | -2116 |
Cryba4 | -1416 |
Dnajb6 | -1244 |
Ubb | 1348 |
Hsf1 | 2256 |
GeneID | Gene Rank |
---|---|
Serpinh1 | -8522 |
Hspb1 | -8520 |
Fkbp4 | -8515 |
Hsph1 | -8479 |
Hspa1b | -8409 |
Hspa1a | -8371 |
Dnajb1 | -8303 |
Hsp90aa1 | -7811 |
Hspa8 | -7724 |
Dedd2 | -7321 |
Ptges3 | -6554 |
Col4a6 | -5419 |
Hsp90ab1 | -4459 |
Rln1 | -3680 |
Ep300 | -2267 |
Mrpl18 | -2116 |
Cryba4 | -1416 |
Dnajb6 | -1244 |
Ubb | 1348 |
Hsf1 | 2256 |
Crebbp | 2884 |
Hspa1l | 3116 |
Hsbp1 | 3840 |
Tnfrsf21 | 6286 |
Hspa2 | 7713 |
PI 3K CASCADE FGFR4
696 | |
---|---|
set | PI 3K CASCADE FGFR4 |
setSize | 11 |
pANOVA | 0.0304 |
s.dist | -0.377 |
p.adjustANOVA | 0.242 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Gab1 | -8223 |
Fgf9 | -8111 |
Fgf2 | -8002 |
Pik3ca | -7797 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Frs2 | -4087 |
Pik3r1 | 2027 |
Ptpn11 | 2062 |
Grb2 | 4493 |
Fgf16 | 7270 |
GeneID | Gene Rank |
---|---|
Gab1 | -8223 |
Fgf9 | -8111 |
Fgf2 | -8002 |
Pik3ca | -7797 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Frs2 | -4087 |
Pik3r1 | 2027 |
Ptpn11 | 2062 |
Grb2 | 4493 |
Fgf16 | 7270 |
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
256 | |
---|---|
set | DOPAMINE NEUROTRANSMITTER RELEASE CYCLE |
setSize | 23 |
pANOVA | 0.00182 |
s.dist | 0.376 |
p.adjustANOVA | 0.0505 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Syn1 | 7354 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Syn2 | 5671 |
Syn3 | 4255 |
Rab3a | 4251 |
Vamp2 | 4007 |
Lin7b | 3533 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cask | 1508 |
Lin7a | 1004 |
Cplx1 | 512 |
Apba1 | 127 |
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Syn1 | 7354 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Syn2 | 5671 |
Syn3 | 4255 |
Rab3a | 4251 |
Vamp2 | 4007 |
Lin7b | 3533 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cask | 1508 |
Lin7a | 1004 |
Cplx1 | 512 |
Apba1 | 127 |
Lin7c | -1316 |
Ppfia1 | -2775 |
Slc18a2 | -8364 |
DEFECTS IN COBALAMIN B12 METABOLISM
217 | |
---|---|
set | DEFECTS IN COBALAMIN B12 METABOLISM |
setSize | 12 |
pANOVA | 0.0277 |
s.dist | -0.367 |
p.adjustANOVA | 0.235 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Mmut | -7915 |
Mtrr | -7591 |
Abcd4 | -6939 |
Mmaa | -6321 |
Mmadhc | -5236 |
Mmachc | -4429 |
Lmbrd1 | -4231 |
Tcn2 | -3809 |
Cd320 | -2432 |
Mtr | -2248 |
Amn | 5929 |
Mmab | 7539 |
GeneID | Gene Rank |
---|---|
Mmut | -7915 |
Mtrr | -7591 |
Abcd4 | -6939 |
Mmaa | -6321 |
Mmadhc | -5236 |
Mmachc | -4429 |
Lmbrd1 | -4231 |
Tcn2 | -3809 |
Cd320 | -2432 |
Mtr | -2248 |
Amn | 5929 |
Mmab | 7539 |
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION
990 | |
---|---|
set | SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION |
setSize | 25 |
pANOVA | 0.00182 |
s.dist | -0.36 |
p.adjustANOVA | 0.0505 |
Top enriched genes
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Taf1a | -6340 |
Sirt1 | -4712 |
H3c15 | -4019 |
Suv39h1 | -3076 |
Taf1d | -2841 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
H3f3b | -414 |
Taf1c | -36 |
GeneID | Gene Rank |
---|---|
H2ac18 | -8348 |
H4c12 | -7747 |
H4c8 | -7477 |
H2bc21 | -7459 |
H2bc6 | -6848 |
H2az2 | -6816 |
H2bc4 | -6707 |
H2bc8 | -6624 |
H4c9 | -6415 |
Taf1a | -6340 |
Sirt1 | -4712 |
H3c15 | -4019 |
Suv39h1 | -3076 |
Taf1d | -2841 |
H2aj | -2603 |
H3f3a | -2297 |
H2az1 | -864 |
H2ac19 | -532 |
H3f3b | -414 |
Taf1c | -36 |
H4c14 | 138 |
Rrp8 | 585 |
Taf1b | 3775 |
H2ax | 4083 |
Tbp | 6609 |
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE
8 | |
---|---|
set | ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE |
setSize | 17 |
pANOVA | 0.0102 |
s.dist | 0.36 |
p.adjustANOVA | 0.137 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Rab3a | 4251 |
Vamp2 | 4007 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cplx1 | 512 |
Chat | 444 |
Slc18a3 | -2007 |
Ppfia1 | -2775 |
Slc5a7 | -5917 |
GeneID | Gene Rank |
---|---|
Stx1a | 7938 |
Unc13b | 7488 |
Stxbp1 | 7232 |
Ppfia3 | 7037 |
Syt1 | 6858 |
Rims1 | 5934 |
Rab3a | 4251 |
Vamp2 | 4007 |
Ppfia4 | 3212 |
Tspoap1 | 2801 |
Snap25 | 2764 |
Ppfia2 | 1867 |
Cplx1 | 512 |
Chat | 444 |
Slc18a3 | -2007 |
Ppfia1 | -2775 |
Slc5a7 | -5917 |
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2
175 | |
---|---|
set | CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 |
setSize | 11 |
pANOVA | 0.0388 |
s.dist | -0.36 |
p.adjustANOVA | 0.275 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ptpn12 | -8331 |
Nras | -8042 |
Hsp90aa1 | -7811 |
Erbin | -7214 |
Kras | -4796 |
Sos1 | -4081 |
Shc1 | -3374 |
Hras | -19 |
Erbb2 | 1862 |
Cdc37 | 3453 |
Grb2 | 4493 |
GeneID | Gene Rank |
---|---|
Ptpn12 | -8331 |
Nras | -8042 |
Hsp90aa1 | -7811 |
Erbin | -7214 |
Kras | -4796 |
Sos1 | -4081 |
Shc1 | -3374 |
Hras | -19 |
Erbb2 | 1862 |
Cdc37 | 3453 |
Grb2 | 4493 |
RRNA PROCESSING IN THE MITOCHONDRION
887 | |
---|---|
set | RRNA PROCESSING IN THE MITOCHONDRION |
setSize | 10 |
pANOVA | 0.0494 |
s.dist | 0.359 |
p.adjustANOVA | 0.306 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Elac2 | 8075 |
Prorp | 6607 |
Tfb1m | 5112 |
Mterf4 | 4202 |
Nsun4 | 3758 |
Trmt10c | 3705 |
Mrm1 | 3236 |
Mrm2 | 678 |
Hsd17b10 | -1176 |
Mrm3 | -3897 |
GeneID | Gene Rank |
---|---|
Elac2 | 8075 |
Prorp | 6607 |
Tfb1m | 5112 |
Mterf4 | 4202 |
Nsun4 | 3758 |
Trmt10c | 3705 |
Mrm1 | 3236 |
Mrm2 | 678 |
Hsd17b10 | -1176 |
Mrm3 | -3897 |
INTERLEUKIN 10 SIGNALING
464 | |
---|---|
set | INTERLEUKIN 10 SIGNALING |
setSize | 19 |
pANOVA | 0.00748 |
s.dist | -0.354 |
p.adjustANOVA | 0.126 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Icam1 | -8494 |
Ccr5 | -8441 |
Cd86 | -8220 |
Il10rb | -8095 |
Il1a | -7481 |
Tnfrsf1b | -7043 |
Lif | -6639 |
Csf1 | -5356 |
Il10ra | -4188 |
Ptafr | -3803 |
Il18 | -3795 |
Cd80 | -1872 |
Tnfrsf1a | -1298 |
Il1r1 | -1016 |
Stat3 | -801 |
Tyk2 | 1654 |
Jak1 | 3233 |
Ptgs2 | 6479 |
Fcer2a | 7586 |
GeneID | Gene Rank |
---|---|
Icam1 | -8494 |
Ccr5 | -8441 |
Cd86 | -8220 |
Il10rb | -8095 |
Il1a | -7481 |
Tnfrsf1b | -7043 |
Lif | -6639 |
Csf1 | -5356 |
Il10ra | -4188 |
Ptafr | -3803 |
Il18 | -3795 |
Cd80 | -1872 |
Tnfrsf1a | -1298 |
Il1r1 | -1016 |
Stat3 | -801 |
Tyk2 | 1654 |
Jak1 | 3233 |
Ptgs2 | 6479 |
Fcer2a | 7586 |
INTERACTION BETWEEN L1 AND ANKYRINS
455 | |
---|---|
set | INTERACTION BETWEEN L1 AND ANKYRINS |
setSize | 29 |
pANOVA | 0.00104 |
s.dist | 0.352 |
p.adjustANOVA | 0.0379 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Scn10a | 8402 |
Sptbn5 | 8340 |
Sptbn2 | 7435 |
Scn8a | 7173 |
Actb | 6914 |
Scn1b | 6803 |
Nrcam | 6783 |
L1cam | 6521 |
Sptan1 | 6269 |
Kcnq2 | 5969 |
Scn2a | 5523 |
Scn3b | 5281 |
Sptb | 4723 |
Actg1 | 4415 |
Sptbn4 | 4260 |
Scn2b | 2738 |
Scn4b | 2575 |
Sptbn1 | 2521 |
Nfasc | 2313 |
Ank2 | 2029 |
GeneID | Gene Rank |
---|---|
Scn10a | 8402 |
Sptbn5 | 8340 |
Sptbn2 | 7435 |
Scn8a | 7173 |
Actb | 6914 |
Scn1b | 6803 |
Nrcam | 6783 |
L1cam | 6521 |
Sptan1 | 6269 |
Kcnq2 | 5969 |
Scn2a | 5523 |
Scn3b | 5281 |
Sptb | 4723 |
Actg1 | 4415 |
Sptbn4 | 4260 |
Scn2b | 2738 |
Scn4b | 2575 |
Sptbn1 | 2521 |
Nfasc | 2313 |
Ank2 | 2029 |
Kcnq3 | 1196 |
Ank3 | -102 |
Ank1 | -1579 |
Scn3a | -1671 |
Scn5a | -1798 |
Scn7a | -2293 |
Scn1a | -2963 |
Scn11a | -5321 |
Scn9a | -6412 |
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
383 | |
---|---|
set | GLYCOGEN BREAKDOWN GLYCOGENOLYSIS |
setSize | 14 |
pANOVA | 0.0227 |
s.dist | -0.352 |
p.adjustANOVA | 0.214 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Phka1 | -7315 |
Gyg | -6772 |
Pygb | -5821 |
Pgm2 | -5358 |
Phkg2 | -4838 |
Phkb | -4393 |
Pygm | -4296 |
Agl | -4222 |
Pygl | -3764 |
Phkg1 | -3017 |
Calm1 | -2523 |
Gaa | 1653 |
Pgm2l1 | 1810 |
Phka2 | 6738 |
GeneID | Gene Rank |
---|---|
Phka1 | -7315 |
Gyg | -6772 |
Pygb | -5821 |
Pgm2 | -5358 |
Phkg2 | -4838 |
Phkb | -4393 |
Pygm | -4296 |
Agl | -4222 |
Pygl | -3764 |
Phkg1 | -3017 |
Calm1 | -2523 |
Gaa | 1653 |
Pgm2l1 | 1810 |
Phka2 | 6738 |
FORMATION OF THE CORNIFIED ENVELOPE
333 | |
---|---|
set | FORMATION OF THE CORNIFIED ENVELOPE |
setSize | 26 |
pANOVA | 0.00204 |
s.dist | 0.349 |
p.adjustANOVA | 0.0528 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Krt9 | 8412 |
St14 | 8252 |
Pkp2 | 8139 |
Evpl | 8122 |
Capn1 | 7941 |
Tchh | 7887 |
Krt20 | 7338 |
Krt77 | 7044 |
Ppl | 6106 |
Perp | 5493 |
Krt73 | 4161 |
Klk8 | 3646 |
Dsc3 | 3280 |
Krt10 | 2444 |
Capns1 | 2360 |
Lor | 2297 |
Furin | 1847 |
Jup | 1021 |
Krt18 | 888 |
Dsp | 735 |
GeneID | Gene Rank |
---|---|
Krt9 | 8412 |
St14 | 8252 |
Pkp2 | 8139 |
Evpl | 8122 |
Capn1 | 7941 |
Tchh | 7887 |
Krt20 | 7338 |
Krt77 | 7044 |
Ppl | 6106 |
Perp | 5493 |
Krt73 | 4161 |
Klk8 | 3646 |
Dsc3 | 3280 |
Krt10 | 2444 |
Capns1 | 2360 |
Lor | 2297 |
Furin | 1847 |
Jup | 1021 |
Krt18 | 888 |
Dsp | 735 |
Krt12 | -969 |
Kazn | -1202 |
Dsg2 | -1722 |
Pcsk6 | -4950 |
Pkp4 | -5313 |
Krt1 | -6628 |
KERATINIZATION
501 | |
---|---|
set | KERATINIZATION |
setSize | 26 |
pANOVA | 0.00204 |
s.dist | 0.349 |
p.adjustANOVA | 0.0528 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Krt9 | 8412 |
St14 | 8252 |
Pkp2 | 8139 |
Evpl | 8122 |
Capn1 | 7941 |
Tchh | 7887 |
Krt20 | 7338 |
Krt77 | 7044 |
Ppl | 6106 |
Perp | 5493 |
Krt73 | 4161 |
Klk8 | 3646 |
Dsc3 | 3280 |
Krt10 | 2444 |
Capns1 | 2360 |
Lor | 2297 |
Furin | 1847 |
Jup | 1021 |
Krt18 | 888 |
Dsp | 735 |
GeneID | Gene Rank |
---|---|
Krt9 | 8412 |
St14 | 8252 |
Pkp2 | 8139 |
Evpl | 8122 |
Capn1 | 7941 |
Tchh | 7887 |
Krt20 | 7338 |
Krt77 | 7044 |
Ppl | 6106 |
Perp | 5493 |
Krt73 | 4161 |
Klk8 | 3646 |
Dsc3 | 3280 |
Krt10 | 2444 |
Capns1 | 2360 |
Lor | 2297 |
Furin | 1847 |
Jup | 1021 |
Krt18 | 888 |
Dsp | 735 |
Krt12 | -969 |
Kazn | -1202 |
Dsg2 | -1722 |
Pcsk6 | -4950 |
Pkp4 | -5313 |
Krt1 | -6628 |
FRS MEDIATED FGFR4 SIGNALING
343 | |
---|---|
set | FRS MEDIATED FGFR4 SIGNALING |
setSize | 13 |
pANOVA | 0.0297 |
s.dist | -0.348 |
p.adjustANOVA | 0.242 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Fgf9 | -8111 |
Nras | -8042 |
Fgf2 | -8002 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Kras | -4796 |
Frs2 | -4087 |
Sos1 | -4081 |
Frs3 | -338 |
Hras | -19 |
Ptpn11 | 2062 |
Grb2 | 4493 |
Fgf16 | 7270 |
GeneID | Gene Rank |
---|---|
Fgf9 | -8111 |
Nras | -8042 |
Fgf2 | -8002 |
Fgf18 | -7611 |
Fgf1 | -7475 |
Kras | -4796 |
Frs2 | -4087 |
Sos1 | -4081 |
Frs3 | -338 |
Hras | -19 |
Ptpn11 | 2062 |
Grb2 | 4493 |
Fgf16 | 7270 |
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
1035 | |
---|---|
set | SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE |
setSize | 15 |
pANOVA | 0.0196 |
s.dist | 0.348 |
p.adjustANOVA | 0.202 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Arf3 | 8239 |
Fig4 | 7690 |
Pi4ka | 7462 |
Arf1 | 6982 |
Pik3r4 | 6435 |
Vac14 | 5967 |
Inpp5e | 5242 |
Pik3c3 | 4940 |
Pi4k2a | 4042 |
Pi4kb | 633 |
Pi4k2b | 371 |
Pikfyve | -700 |
Ocrl | -1264 |
Pik3c2a | -4493 |
Sacm1l | -7466 |
GeneID | Gene Rank |
---|---|
Arf3 | 8239 |
Fig4 | 7690 |
Pi4ka | 7462 |
Arf1 | 6982 |
Pik3r4 | 6435 |
Vac14 | 5967 |
Inpp5e | 5242 |
Pik3c3 | 4940 |
Pi4k2a | 4042 |
Pi4kb | 633 |
Pi4k2b | 371 |
Pikfyve | -700 |
Ocrl | -1264 |
Pik3c2a | -4493 |
Sacm1l | -7466 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
1088 | |
---|---|
set | TRAF3 DEPENDENT IRF ACTIVATION PATHWAY |
setSize | 13 |
pANOVA | 0.0312 |
s.dist | -0.345 |
p.adjustANOVA | 0.242 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Irf7 | -8101 |
Tbk1 | -5931 |
Traf3 | -5653 |
Rnf135 | -4521 |
Sike1 | -3450 |
Trim25 | -2446 |
Ep300 | -2267 |
Ddx58 | -2254 |
Mavs | -1764 |
Irf3 | -1173 |
Crebbp | 2884 |
Ikbke | 4612 |
GeneID | Gene Rank |
---|---|
Ifih1 | -8330 |
Irf7 | -8101 |
Tbk1 | -5931 |
Traf3 | -5653 |
Rnf135 | -4521 |
Sike1 | -3450 |
Trim25 | -2446 |
Ep300 | -2267 |
Ddx58 | -2254 |
Mavs | -1764 |
Irf3 | -1173 |
Crebbp | 2884 |
Ikbke | 4612 |
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION
753 | |
---|---|
set | PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION |
setSize | 23 |
pANOVA | 0.00441 |
s.dist | -0.343 |
p.adjustANOVA | 0.0968 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Nfkb2 | -7543 |
Il1a | -7481 |
C3ar1 | -7353 |
Pycard | -7241 |
Entpd1 | -6854 |
Sugt1 | -6360 |
Casp1 | -5869 |
Rela | -5667 |
Nlrp3 | -5663 |
Nfkb1 | -5333 |
Entpd5 | -5215 |
Txnip | -4663 |
Hsp90ab1 | -4459 |
Il18 | -3795 |
P2rx7 | -1704 |
P2rx4 | -723 |
C3 | -711 |
Hmox1 | -613 |
Pstpip1 | 447 |
Txn1 | 2081 |
GeneID | Gene Rank |
---|---|
Nfkb2 | -7543 |
Il1a | -7481 |
C3ar1 | -7353 |
Pycard | -7241 |
Entpd1 | -6854 |
Sugt1 | -6360 |
Casp1 | -5869 |
Rela | -5667 |
Nlrp3 | -5663 |
Nfkb1 | -5333 |
Entpd5 | -5215 |
Txnip | -4663 |
Hsp90ab1 | -4459 |
Il18 | -3795 |
P2rx7 | -1704 |
P2rx4 | -723 |
C3 | -711 |
Hmox1 | -613 |
Pstpip1 | 447 |
Txn1 | 2081 |
Nt5e | 3971 |
App | 6496 |
Gsdmd | 6789 |
DSCAM INTERACTIONS
267 | |
---|---|
set | DSCAM INTERACTIONS |
setSize | 10 |
pANOVA | 0.0607 |
s.dist | 0.343 |
p.adjustANOVA | 0.334 |
Top enriched genes
GeneID | Gene Rank |
---|---|
Pak1 | 7075 |
Mapk11 | 6893 |
Dscaml1 | 5224 |
Ntn1 | 4776 |
Dscam | 3786 |
Mapk8 | 3304 |
Mapk14 | 100 |
Dcc | -470 |
Mapk12 | -499 |
Rac1 | -1278 |
GeneID | Gene Rank |
---|---|
Pak1 | 7075 |
Mapk11 | 6893 |
Dscaml1 | 5224 |
Ntn1 | 4776 |
Dscam | 3786 |
Mapk8 | 3304 |
Mapk14 | 100 |
Dcc | -470 |
Mapk12 | -499 |
Rac1 | -1278 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report